10-Q: Quarterly report pursuant to Section 13 or 15(d)
Published on February 6, 2007
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For
the
quarterly period ended December 31, 2006.
OR
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For
the
transition period from __________to __________
Commission
File Number: 0-21184
![](mich4c.jpg)
MICROCHIP
TECHNOLOGY INCORPORATED
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
86-0629024
|
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
(IRS
Employer Identification No.)
|
2355
W. Chandler Blvd., Chandler, AZ 85224-6199
(480)
792-7200
(Address,
Including Zip Code, and Telephone Number,
Including
Area Code, of Registrant’s
Principal
Executive Offices)
Indicate
by checkmark whether the registrant (1) has filed all reports required to
be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to the filing requirements
for
the past 90 days.
Yes
x No
¨
Indicate
by checkmark whether the registrant is a large accelerated filer, an accelerated
filer or a non-accelerated filer. See definition of “accelerated filer and large
accelerated filer” in Rule 12b-2 of the Exchange Act.
Large
Accelerated Filer x
|
Accelerated
filer ¨
|
Non-accelerated
filer ¨
|
Indicate
by checkmark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act). (Check One)
Yes
¨ No
x
Shares
Outstanding of Registrant’s Common Stock
|
|
Class
|
Outstanding
at January
31,
2007
|
Common
Stock, $0.001 par value
|
216,092,607
shares
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
INDEX
Page
|
||
PART
I. FINANCIAL INFORMATION
|
||
Item
1.
|
Financial
Statements (Unaudited)
|
|
3
|
||
4
|
||
5
|
||
6
|
||
15
|
||
30
|
||
30
|
||
31
|
||
31
|
||
40
|
||
CERTIFICATIONS
|
||
2
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands, except share and per share amounts)
ASSETS
|
|||||||
December
31,
|
March
31,
|
||||||
2006
|
2006
|
||||||
(Unaudited)
|
(Note
1)
|
||||||
Cash
and cash equivalents
|
$
|
153,277
|
$
|
565,273
|
|||
Short-term
investments
|
575,275
|
199,491
|
|||||
Accounts
receivable, net
|
120,085
|
139,361
|
|||||
Inventories
|
121,850
|
115,024
|
|||||
Prepaid
expenses
|
15,929
|
11,369
|
|||||
Deferred
tax assets
|
68,991
|
78,544
|
|||||
Other
current assets
|
11,137
|
9,767
|
|||||
Total
current assets
|
1,066,544
|
1,118,829
|
|||||
Property,
plant and equipment, net
|
624,996
|
659,972
|
|||||
Long-term
investments
|
536,008
|
520,360
|
|||||
Goodwill
|
31,886
|
31,886
|
|||||
Intangible
assets, net
|
8,767
|
9,489
|
|||||
Other
assets
|
10,259
|
10,060
|
|||||
Total
assets
|
$
|
2,278,460
|
$
|
2,350,596
|
|||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||
Short-term
debt
|
$
|
29,500
|
$
|
268,954
|
|||
Accounts
payable
|
34,742
|
50,847
|
|||||
Accrued
liabilities
|
218,494
|
189,687
|
|||||
Deferred
income on shipments to distributors
|
92,135
|
99,481
|
|||||
Total
current liabilities
|
374,871
|
608,969
|
|||||
Pension
accrual
|
892
|
801
|
|||||
Deferred
tax liability
|
13,205
|
14,637
|
|||||
Stockholders'
equity:
|
|||||||
Preferred
stock, $.001 par value; authorized 5,000,000 shares;
|
|||||||
no
shares issued or outstanding.
|
---
|
---
|
|||||
Common
stock, $.001 par value; authorized 450,000,000 shares;
|
|||||||
issued
and outstanding 216,038,252 shares at December 31, 2006;
issued and outstanding 213,614,343 shares at
March 31, 2006.
|
216
|
214
|
|||||
Additional
paid-in capital
|
713,611
|
639,238
|
|||||
Retained
earnings
|
1,185,152
|
1,106,355
|
|||||
Deferred
share-based compensation
|
---
|
(5,705
|
)
|
||||
Accumulated
other comprehensive loss
|
(9,487
|
)
|
(13,913
|
)
|
|||
Net
stockholders' equity
|
1,889,492
|
1,726,189
|
|||||
Total
liabilities and stockholders' equity
|
$
|
2,278,460
|
$
|
2,350,596
|
|||
See
accompanying notes to condensed consolidated financial
statements
|
3
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands except per share amounts)
(Unaudited)
Three
Months Ended December 31,
|
Nine
Months Ended December 31,
|
||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||
Net
sales
|
$
|
251,004
|
$
|
234,896
|
$
|
781,495
|
$
|
680,721
|
|||
Cost
of sales (1)
|
|
101,294
|
|
94,626
|
|
311,340
|
|
278,390
|
|||
Gross
profit
|
149,710
|
140,270
|
470,155
|
402,331
|
|||||||
Operating
expenses:
|
|||||||||||
Research
and development (1)
|
28,043
|
23,377
|
85,151
|
70,409
|
|||||||
Selling,
general and administrative (1)
|
|
40,185
|
|
32,305
|
|
122,482
|
|
95,010
|
|||
68,228
|
55,682
|
207,633
|
165,419
|
||||||||
Operating
income
|
81,482
|
84,588
|
262,522
|
236,912
|
|||||||
Other
income (expense):
|
|||||||||||
Interest
income
|
15,002
|
8,668
|
43,910
|
22,766
|
|||||||
Interest
expense
|
(890)
|
(559)
|
(5,146)
|
(1,497)
|
|||||||
Other,
net
|
|
260
|
|
374
|
|
452
|
|
1,572
|
|||
Income
before income taxes
|
95,854
|
93,071
|
301,738
|
259,753
|
|||||||
Income
tax provision
|
|
23,005
|
|
52,947
|
|
72,417
|
|
92,952
|
|||
Net
income
|
$
|
72,849
|
$
|
40,124
|
$
|
229,321
|
$
|
166,801
|
|||
Basic
net income per common share
|
$
|
0.34
|
$
|
0.19
|
$
|
1.07
|
$
|
0.80
|
|||
Diluted
net income per common share
|
$
|
0.33
|
$
|
0.19
|
$
|
1.04
|
$
|
0.78
|
|||
Dividends
declared per common share
|
$
|
0.250
|
$
|
0.160
|
$
|
0.700
|
$
|
0.380
|
|||
Weighted
average common shares outstanding
|
|
215,710
|
|
210,836
|
|
214,603
|
|
209,556
|
|||
Weighted
average common and potential
|
|||||||||||
common
shares outstanding
|
|
220,920
|
|
215,667
|
|
219,837
|
|
214,293
|
|||
(1)
Includes share-based compensation charges as follow:
|
|||||||||||
Cost
of sales
|
$
|
1,595
|
$
|
---
|
$
|
1,595
|
$
|
---
|
|||
Research
and development
|
2,432
|
73
|
7,245
|
94
|
|||||||
Selling,
general and administrative
|
3,714
|
118
|
10,874
|
182
|
|||||||
See
accompanying notes to condensed consolidated financial
statements
|
4
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands)
(Unaudited)
Nine
months ended December 31,
|
|||||||
2006
|
2005
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
income
|
$
|
229,321
|
$
|
166,801
|
|||
Adjustments
to reconcile net income to net cash provided by operating
|
|||||||
activities:
|
|||||||
Depreciation
and amortization
|
87,792
|
83,106
|
|||||
Deferred
income taxes
|
7,563
|
37,139
|
|||||
Share-based
compensation
|
19,714
|
276
|
|||||
Excess
tax benefit from share-based payment arrangements
|
(14,648
|
)
|
---
|
||||
Tax
benefit from equity incentive plans
|
14,659
|
17,651
|
|||||
Gain
on sale of assets
|
(364
|
)
|
(476
|
)
|
|||
Changes
in operating assets and liabilities:
|
|||||||
Decrease
in accounts receivable
|
19,276
|
1,113
|
|||||
Increase
in inventories
|
(3,422
|
)
|
(10,911
|
)
|
|||
Decrease
in deferred income on shipments to distributors
|
(7,346
|
)
|
(7,057
|
)
|
|||
Increase
in accounts payable and accrued liabilities
|
12,702
|
39,147
|
|||||
Change
in other assets and liabilities
|
(7,422
|
)
|
(3,730
|
)
|
|||
Net
cash provided by operating activities
|
357,825
|
323,059
|
|||||
Cash
flows from investing activities:
|
|||||||
Purchases
of investments
|
(1,087,068
|
)
|
(531,852
|
)
|
|||
Sales
and maturities of investments
|
700,620
|
360,648
|
|||||
Investment
in other assets
|
(673
|
)
|
(1,704
|
)
|
|||
Proceeds
from sale of assets
|
1,746
|
819
|
|||||
Capital
expenditures
|
(51,416
|
)
|
(42,817
|
)
|
|||
Net
cash used in investing activities
|
(436,791
|
)
|
(214,906
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Payment
of cash dividend
|
(150,526
|
)
|
(79,612
|
)
|
|||
Repurchase
of common stock
|
---
|
(3,320
|
)
|
||||
Proceeds
from sale of common stock
|
42,302
|
63,501
|
|||||
Excess
tax benefit from share-based payment arrangements
|
14,648
|
---
|
|||||
Payments
on short-term borrowings
|
(239,454
|
)
|
---
|
||||
Net
cash used in financing activities
|
(333,030
|
)
|
(19,431
|
)
|
|||
Net
(decrease) increase in cash and cash equivalents
|
(411,996
|
)
|
88,722
|
||||
Cash
and cash equivalents at beginning of period
|
565,273
|
68,730
|
|||||
Cash
and cash equivalents at end of period
|
$
|
153,277
|
$
|
157,452
|
|||
See
accompanying notes to condensed consolidated financial
statements
|
5
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(Unaudited)
(1)
|
Basis
of Presentation
|
The
accompanying unaudited condensed consolidated financial statements include
the
accounts of Microchip Technology Incorporated and its wholly-owned subsidiaries
(the “Company”). All intercompany balances and transactions have been eliminated
in consolidation. We own 100% of the outstanding stock
in all
of our subsidiaries.
The
accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles in the
United States of America, pursuant to the rules and regulations of the
Securities and Exchange Commission (the “SEC”). In the opinion of management,
all adjustments of a normal recurring nature which are necessary for a fair
presentation have been included. Certain information and footnote disclosures
normally included in audited consolidated financial statements have been
condensed or omitted pursuant to such SEC rules and regulations. It is suggested
that these condensed consolidated financial statements be read in conjunction
with the audited consolidated financial statements and the notes thereto
included in the Company’s Annual Report on Form 10-K for the fiscal year ended
March 31, 2006. The results of operations for the three and nine months ended
December 31, 2006 are not necessarily indicative of the results that may
be
expected for the fiscal year ending March 31, 2007 or for any other
period.
(2)
|
Recently
Issued Accounting
Pronouncements
|
In
July
2006, the FASB issued FASB Interpretation No. 48, Accounting
for Uncertainty in Income Taxes
(“FIN
48”). FIN 48 is an interpretation of FASB Statement No. 109, Accounting
for Income Taxes,
and it
seeks to reduce the diversity in practice associated with certain aspects
of
measurement and recognition in accounting for income taxes. In addition,
FIN 48
requires expanded disclosure with respect to the uncertainty in income taxes
and
is effective for the Company as of the beginning fiscal 2008. The Company
is
currently evaluating the impact, if any, that FIN 48 will have on its financial
statements.
In
September 2006, the FASB issued SFAS No. 157, Fair
Value Measurements
(“SFAS
157”). SFAS 157 defines fair value, establishes a framework for measuring fair
value in accordance with generally accepted accounting principles, and expands
disclosures about fair value measurements. The provisions of SFAS 157 are
effective for fiscal years beginning after November 15, 2007. The Company
is
currently evaluating the impact, if any, that SFAS 157 will have on its
financial statements.
In
September 2006, the FASB issued SFAS 158, Employers’
Accounting for Defined Benefit Pension and Other Postretirement Plans, an
amendment of FASB Statements No. 87, 88, 106 and 132(R)
(“SFAS
158”) and is effective for the Company’s fiscal year ended March 31, 2007. This
standard requires companies to recognize, on a prospective basis, the funded
status of their defined benefit pension and other postretirement benefit
plans
as a net liability or asset on their balance sheets. The Company is currently
evaluating the impact, if any, that SFAS 158 will have on its financial
statements.
(3)
|
Share-Based
Compensation
|
The
Company has equity incentive plans under which non-qualified stock options
and
restricted stock units (RSUs) have been granted to employees and under which
non-qualified stock options have been granted to non-employee members of
the
Board of Directors. In the second half of fiscal 2006, the Company adopted
RSUs
as its primary equity incentive compensation instrument for employees. The
Company also has an employee stock purchase plan for all eligible employees.
Effective April 1, 2006, the Company adopted FASB Statement of Financial
Accounting Standards (“SFAS”) No. 123R (revised 2004),
Share-Based Payment
(“SFAS 123R”). SFAS 123R requires all share-based payments to
employees, including grants of employee stock options, RSUs
6
and
employee stock purchase rights, to be recognized in the financial statements
based on their respective grant date fair values and does not allow the
previously permitted pro forma disclosure-only method as an alternative to
financial statement recognition. SFAS 123R supersedes Accounting Principles
Board Opinion No. 25,
Accounting for Stock Issued to Employees
(“APB 25”) and related interpretations, and amends
SFAS No. 95,
Statement of Cash Flows.
SFAS 123R also requires the benefits of tax deductions in excess of
recognized compensation cost be reported as a financing cash flow, rather
than
as an operating cash flow as required under previous literature. This
requirement may reduce the Company’s future net operating cash flows and
increase net financing cash flows. In March 2005, the SEC issued
SAB No. 107,
Share-Based Payment
(“SAB 107”), which provides guidance regarding the interaction of
SFAS 123R and certain SEC rules and regulations. The Company has applied
the provisions of SAB 107 in its adoption of SFAS 123R.
The
Company adopted SFAS 123R using the modified-prospective method of
recognition of compensation expense related to share-based payments. The
Company’s unaudited condensed consolidated statement of income for the three and
nine months ended December 31, 2006 reflects the impact of adopting
SFAS 123R. In accordance with the modified-prospective transition method,
the Company’s unaudited condensed consolidated statements of income for prior
periods have
not
been
restated to reflect, and do not include, the impact of
SFAS 123R.
SFAS 123R
requires companies to estimate the fair value of share-based payment awards
on
the date of grant using an option pricing model. The value of the portion
of the
award that is ultimately expected to vest is recognized as expense ratably
over
the requisite service periods. The Company has estimated the fair value of
each
award as of the date of grant using the Black-Scholes option pricing model,
which was developed for use in estimating the value of traded options that
have
no vesting restrictions and that are freely transferable. The Black-Scholes
model considers, among other factors, the expected life of the award and
the
expected volatility of the Company’s stock price. Although the Black-Scholes
model meets the requirements of SFAS 123R and SAB 107, the fair values
generated by the model may not be indicative of the actual fair values of
the
Company’s awards as it does not consider other factors important to those
share-based payment awards such as, continued employment, periodic vesting
requirements, and limited transferability.
Prior
to
the adoption of SFAS 123R, the Company presented all tax benefits of
deductions resulting from the exercise of stock options as operating cash
flows
in the condensed consolidated statements of cash flows. SFAS 123R requires
the cash flows resulting from the tax benefits arising from tax deductions
in
excess of the compensation cost recognized for the equity incentives (excess
tax
benefits) to be classified as financing cash flows. The $14.6 million excess
tax
benefit classified as a financing cash inflow in the Company’s accompanying
condensed consolidated statements of cash flows for the nine months ending
December 31, 2006 would have been classified as an operating cash inflow
if the
Company had not adopted SFAS 123R.
Prior
to
the adoption of SFAS 123R, the Company accounted for share-based payment
awards to employees in accordance with APB 25 and related interpretations,
and had adopted the disclosure-only alternative of
SFAS No. 123,
Accounting for Stock-Based Compensation
(“SFAS 123”), and SFAS No. 148,
Accounting for Stock-Based Compensation — Transition and
Disclosure.
In
accordance with APB 25, share-based compensation expense was not recorded
in connection with share-based payment awards granted with exercise prices
equal
to or greater than the fair market value of the Company’s common stock on the
date of grant, unless certain modifications were subsequently made. The Company
recorded deferred compensation in connection with RSUs equal to the fair
market
value of the common stock on the date of grant. Recorded deferred compensation
was recognized as share-based compensation expense ratably over the applicable
vesting periods. In accordance with the provisions of SFAS 123R, all
deferred compensation previously recorded has been eliminated with a
corresponding reduction in additional paid in capital.
Determining
the appropriate fair-value model and calculating the fair value of share-based
awards at the date of grant requires judgment. The Company uses the
Black-Scholes option pricing model to estimate the fair value of employee
stock
options and rights to purchase shares under stock participation plans,
consistent with the
7
provisions
of SFAS 123R. Option pricing models, including the Black-Scholes model,
also require the use of input assumptions, including expected volatility,
expected life, expected dividend rate, and expected risk-free rate of return.
The Company uses a blend of historical and implied volatility based on options
freely traded in the open market as it believes this is more reflective of
market conditions and a better indicator of expected volatility than using
purely historical volatility. The expected life of the awards is based on
historical and other economic data trended into the future. The risk-free
interest rate assumption is based on observed interest rates appropriate
for the
terms of the Company’s awards. The dividend yield assumption is based on the
Company’s history and expectation of future dividend payouts. The fair value of
our RSUs is based on the fair market value of the Company’s common stock on the
date of grant discounted for expected future dividends. SFAS 123R requires
the Company to develop an estimate of the number of share-based awards which
will be forfeited due to employee turnover. Quarterly changes in the estimated
forfeiture rate may have a significant effect on share-based compensation,
as
the effect of adjusting the rate for all expense amortization after April
1,
2006 is recognized in the period the forfeiture estimate is changed. If the
actual forfeiture rate is higher than the estimated forfeiture rate, then
an
adjustment is made to increase the estimated forfeiture rate, which will
result
in a decrease to the expense recognized in the financial statements. If the
actual forfeiture rate is lower than the estimated forfeiture rate, then
an
adjustment is made to decrease the estimated forfeiture rate, which will
result
in an increase to the expense recognized in the financial statements. If
forfeiture adjustments are made, they would affect the Company’s gross margin,
research and development expenses, and selling, general, and administrative
expenses. The effect of forfeiture adjustments in the third quarter of fiscal
2007 was immaterial.
The
Company evaluates the assumptions used to value its awards on a quarterly
basis.
If factors change and the Company employs different assumptions, share-based
compensation expense may differ significantly from what was recorded in the
past. If there are any modifications or cancellations of the underlying unvested
securities, the Company may be required to accelerate, increase or cancel
any
remaining unearned share-based compensation expense. Future share-based
compensation expense and unearned share-based compensation will increase
to the
extent that the Company grants additional equity awards to employees or it
assumes unvested equity awards in connection with acquisitions. Had the Company
adopted SFAS 123R in prior periods, the magnitude of the impact of that
standard on its results of operations would have approximated the impact
of
SFAS 123 assuming the application of the Black-Scholes option pricing model
as described in the disclosure of pro forma net income and pro forma net
income
per share in Note 10 to the Company’s Unaudited Condensed Consolidated
Financial Statements.
(4)
|
Investments
|
The
Company’s investments are intended to establish a high-quality portfolio that
preserves principal, meets liquidity needs, avoids inappropriate concentrations
and delivers an appropriate yield in relationship to the Company’s investment
guidelines and market conditions. The following is a summary of
available-for-sale securities at December 31, 2006 (amounts in thousands):
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
||||||||||
|
|||||||||||||
State
student loan bonds
|
$
|
43,425
|
$
|
---
|
$
|
---
|
$
|
43,425
|
|||||
Government
agency bonds
|
740,564
|
---
|
10,528
|
730,036
|
|||||||||
Commercial
paper
|
10,000
|
---
|
25
|
9,975
|
|||||||||
Floating
rate securities
|
329,035
|
---
|
1,188
|
327,847
|
|||||||||
$
|
1,123,024
|
$
|
---
|
$
|
11,741
|
$
|
1,111,283
|
During
the three and nine months ended December 31, 2006, the Company did not have
any
gross realized gains or losses on sales of available-for-sale securities.
During
the three and nine months ended December 31, 2005, the Company had gross
realized losses on available-for-sale securities of eight thousand
dollars.
8
At
December 31, 2006, the
Company evaluated its investment portfolio, and noted unrealized losses of
$11.7 million due to fluctuations in interest rates. Management does not
believe any of the unrealized losses represented an other-than-temporary
impairment based on its evaluation of available evidence as of December 31,
2006. The Company’s intent is to hold these investments until such time as these
assets are no longer impaired. For those investments not scheduled to mature
until after December 31, 2007, such recovery is not anticipated to occur
in the
next year and these investments have been classified as long-term investments.
At December 31, 2006, short-term investments consisted of $575.3 million
and long-term investments consisted of $536.0 million.
The
amortized cost and estimated fair value of the available-for-sale securities
at
December 31, 2006, by maturity, are shown below (amounts in thousands). Expected
maturities can differ from contractual maturities because the issuers of
the
securities may have the right to prepay obligations without prepayment
penalties, and the Company views its available-for-sale securities as available
for current operations.
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
||||||||||
Available-for-sale
|
|||||||||||||
Due
in one year or less
|
$
|
576,741
|
$
|
---
|
$
|
1,466
|
$
|
575,275
|
|||||
Due
after one year and through five
years
|
546,283
|
---
|
10,275
|
536,008
|
|||||||||
$
|
1,123,024
|
$
|
---
|
$
|
11,741
|
$
|
1,111,283
|
The
following table shows the gross unrealized losses and fair value of the
Company’s investments with unrealized losses that are not deemed to be other
than temporarily impaired, aggregated by investment category and length of
time
that individual securities have been in a continuous unrealized loss position
at
December 31, 2006 (amounts in thousands):
Less
Than 12 Months
|
Greater
Than 12 Months
|
||||||||||||
Fair
Value
|
Gross
Unrealized Loss
|
Fair
Value
|
Gross
Unrealized Loss
|
||||||||||
State
student loan bonds
|
$
|
43,425
|
$
|
---
|
$
|
---
|
$
|
---
|
|||||
Government
agency
|
218,464
|
817
|
511,572
|
9,711
|
|||||||||
Commercial
paper
|
9,975
|
25
|
---
|
---
|
|||||||||
Floating
rate securities
|
303,411
|
624
|
24,436
|
564
|
|||||||||
$
|
575,275
|
$
|
1,466
|
$
|
536,008
|
$
|
10,275
|
The
unrealized losses on the Company’s investments were caused by interest rate
increases. The contractual cash flows of those investments are either guaranteed
by a government agency or are investments in corporations with credit ratings
of
AA or higher. Accordingly, it is expected that the securities will not settle
at
prices less than the amortized cost of the Company’s investment.
Because
the Company has the ability and intent to hold these investments until a
recovery of fair value, which may be maturity, it does not consider the
investments with unrealized losses to be other than temporarily impaired
at
December 31, 2006.
9
(5)
|
Accounts
Receivable
|
Accounts
receivable consists of the following (amounts in thousands):
December
31,
2006
|
March
31,
2006
|
||||||
Trade
accounts receivable
|
$
|
123,126
|
$
|
142,703
|
|||
Other
|
502
|
320
|
|||||
123,628
|
143,023
|
||||||
Less
allowance for doubtful accounts
|
3,543
|
3,662
|
|||||
$
|
120,085
|
$
|
139,361
|
(6)
|
Inventories
|
The
components of inventories consist of the following (amounts in
thousands):
December
31,
2006
|
March
31,
2006
|
||||||
Raw
materials
|
$
|
4,974
|
$
|
3,505
|
|||
Work
in process
|
82,267
|
80,947
|
|||||
Finished
goods
|
34,609
|
30,572
|
|||||
$
|
121,850
|
$
|
115,024
|
Inventory
impairment charges establish a new cost basis for inventory and charges are
not
subsequently reversed to income even if circumstances later suggest that
increased carrying amounts are recoverable.
(7)
|
Property,
Plant and Equipment
|
Property,
plant and equipment consists of the following (amounts in
thousands):
December
31,
2006
|
March
31,
2006
|
||||||
Land
|
$
|
47,212
|
$
|
47,212
|
|||
Building
and building improvements
|
371,717
|
366,055
|
|||||
Machinery
and equipment
|
1,050,242
|
991,452
|
|||||
Projects
in process
|
72,308
|
87,341
|
|||||
1,541,479
|
1,492,060
|
||||||
Less
accumulated depreciation and
amortization
|
916,483
|
832,088
|
|||||
$
|
624,996
|
$
|
659,972
|
Depreciation
expense attributed to property and equipment was $86.4 million in the nine
months ended December 31, 2006 and $82.2 million in the nine months ended
December 31, 2005.
(8)
|
Short-term
Debt
|
The
Company had short-term debt of $29.5 million and $269.0 million at December
31,
2006 and March 31, 2006, respectively. The short-term debt is a result of
repurchase agreements that are in place with an investment brokerage. The
short-term debt was collateralized with $47.3 million and
$277.6 million of available-for-sale investments at December 31, 2006 and
March 31, 2006, respectively. The short-term debt had a weighted
10
average
interest rate of 5.32% and 4.83% as of December 31, 2006 and March 31, 2006,
respectively. In fiscal 2006, the borrowings were made to complete a $500
million repatriation of foreign earnings under the American Jobs Creation
Act.
The borrowings were collateralized against investments that are held by the
Company’s offshore subsidiaries. The Company presently intends to pay down the
short-term borrowings as the investments mature and also from future offshore
cash generation. In the nine months ended December 31, 2006, $239.5 million
of short-term borrowings were paid down. There are no covenants associated
with
the repurchase agreements.
(9)
|
Comprehensive
Income
|
Comprehensive
income consists of net income and net unrealized gains (losses) on
available-for-sale investments. The components of other comprehensive income
(loss) and related tax effects were as follows (amounts in
thousands):
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
(Decrease)
increase in unrealized losses on investments, net of tax effect
of
$112,
$400,
($558) and $280, respectively
|
$
|
(487
|
)
|
$
|
2,107
|
$
|
(4,426
|
)
|
$
|
1,900
|
(10)
|
Employee
Benefit Plans
|
Equity
Incentive Plans
The
Company has equity incentive plans under which incentive stock options have
been
granted to employees and RSUs and non-qualified stock options have been granted
to employees and under which non-qualified stock options have been granted
to
non-employee members of the Board of Directors. The Company’s 2004 Equity
Incentive Plan, as amended and restated (the “2004 Plan”), is shareholder
approved and permits the grant of stock options and RSUs to employees,
non-employee members of the Board of Directors and consultants. At December
31,
2006, 12.0 million shares remained available for future grant under the
2004 Plan. Stock options and RSUs are designed to reward employees for their
long-term contributions to the Company and to provide incentive for them
to
remain employed with the Company. The Company believes that such awards better
align the interests of its employees with those of its shareholders.
The
Board
of Directors or the plan administrator determines eligibility, vesting schedules
and exercise prices for equity incentives granted under the plans. Equity
incentives granted generally have a term of 10 years, and in the case of
newly
hired employees generally vest and become exercisable at the rate of 25%
after
one year of service and ratably on a monthly or quarterly basis over a period
of
36 months thereafter; subsequent equity incentive grants to existing employees
generally vest and become exercisable ratably on a monthly or quarterly basis
over a period starting in 48 months and ending in 60 months after the date
of
grant.
Share-Based
Compensation Expense
The
following table presents details of share-based compensation expense resulting
from the application of SFAS 123R (amounts in thousands):
11
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
||||||||||||
2006(1)
|
2005
|
2006(1)
|
2005
|
||||||||||
Cost
of sales
|
$
|
1,595(2
|
)
|
$
|
---
|
$
|
1,595(2
|
)
|
$
|
---
|
|||
Research
and development
|
2,431
|
73
|
7,244
|
94
|
|||||||||
Selling,
general and administrative
|
3,714
|
118
|
10,874
|
182
|
|||||||||
Share-based
compensation effects in income
before taxes
|
7,740
|
191
|
19,713
|
276
|
|||||||||
Income
taxes
|
1,857
|
46
|
4,730
|
66
|
|||||||||
Net
share-based compensation effects in net
income
|
$
|
5,883
|
$
|
145
|
$
|
14,983
|
$
|
210
|
|||||
Share-based
compensation effects on base earnings
per common share
|
$
|
0.02
|
$
|
---
|
$
|
0.07
|
$
|
---
|
|||||
Share-based
compensation effects on diluted
earnings per common share
|
$
|
0.03
|
$
|
---
|
$
|
0.07
|
$
|
---
|
(1)
The
amounts included in the three and nine months ended December 31, 2006 reflect
the adoption of SFAS 123R. In accordance with the modified prospective
transition method, the Company’s unaudited condensed consolidated statements of
income for prior periods have not been restated to reflect, and do not include,
the impact of SFAS 123R.
(2)
During the three months ended December 31, 2006, $1.7 million
was capitalized to inventory, of which none was sold. During the nine months
ended December 31, 2006, $5.0 million was capitalized to inventory of which
$1.6 million was sold.
The
amount of unearned share-based compensation currently estimated to be expensed
in the remainder of fiscal 2007 through fiscal 2012 related to unvested
share-based payment awards at December 31, 2006 is $71.0 million. The
weighted average period over which the unearned share-based compensation
is
expected to be recognized is approximately 2.25 years.
In
accordance with the requirements of the disclosure-only alternative of SFAS
123,
set forth below is a pro forma illustration of the effect on net income and
net
income per share computed as if the Company had valued share-based awards
to
employees using the Black-Scholes option pricing model instead of applying
the
guidelines provided by APB 25 in the three and nine months ended December
31,
2005 (in thousands, except per share amounts):
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
||||||
2005
|
2005
|
||||||
Net
income, as reported
|
$
|
40,124
|
$
|
166,801
|
|||
Deduct:
Total share-based employee compensation expense determined under
fair
value methods for all awards,
net of related tax effects.
|
3,432
|
12,769
|
|||||
Pro
forma net income
|
$
|
36,692
|
$
|
154,032
|
|||
Net
income per common share:
|
|||||||
Basic,
as reported
|
$
|
0.19
|
$
|
0.80
|
|||
Basic,
pro forma
|
$
|
0.17
|
$
|
0.74
|
|||
Diluted,
as reported
|
$
|
0.19
|
$
|
0.78
|
|||
Diluted,
pro forma
|
$
|
0.17
|
$
|
0.72
|
Combined
Incentive Plan Information
RSU
activity under the 2004 Plan in the nine months ended December 31, 2006 is
set
forth below:
12
Number
of Shares
|
||||
Balance
at March 31, 2006
|
195,524
|
|||
Restricted
stock units granted under the 2004 Plan
|
1,598,038
|
|||
Restricted
stock units cancelled
|
(79,279
|
)
|
||
Restricted
stock units vested
|
(12,438
|
)
|
||
Balance
at December 31, 2006
|
1,701,845
|
The
total
pre-tax intrinsic value of RSUs which vested during the three and nine months
ended December 31, 2006 was immaterial. The aggregate pre-tax intrinsic
value of RSUs outstanding at December 31, 2006 was $55.4 million. The aggregate
pre-tax intrinsic value was calculated based on the closing price of the
Company’s common stock of $32.70 on December 29, 2006. At December 31, 2006, the
weighted average remaining expense recognition period was 2.67
years.
The
weighted average fair values per share of the RSUs awarded in the three and
nine
months ended December 31, 2006 were $27.16 and $31.41, respectively, calculated
based on the fair market value of the Company’s common stock on the respective
grant dates discounted for the Company’s expected dividend yield. The weighted
average fair values per share of RSUs awarded in the three and nine months
ended
December 31, 2005 were $30.85 and $27.91, respectively, calculated based
on the
intrinsic value of the instrument on the date of grant.
Option
activity under the Company’s stock incentive plans in the nine months ended
December 31, 2006 is set forth below:
Number
of Shares
|
Weighted
Average
Exercise
Price
per Share
|
||||||
Balance
at March 31, 2006
|
18,450,360
|
$
|
20.97
|
||||
Options
granted under the 2004 Plan
|
58,208
|
34.63
|
|||||
Options
cancelled
|
(318,989
|
)
|
24.28
|
||||
Options
exercised
|
(2,208,295
|
)
|
16.39
|
||||
Balance
at December 31, 2006
|
15,981,284
|
$
|
21.58
|
The
total
pre-tax intrinsic value of options exercised during the three and nine months
ended December 31, 2006 was $9.0 million and $40.3 million,
respectively. This intrinsic value represents the difference between the
fair
market value of the Company’s common stock on the date of exercise and the
exercise price of each equity award.
The
following table summarizes information about the stock options outstanding
at
December 31, 2006:
Range
of Exercise
Prices
|
Number
of Outstanding
|
Weighted
Average Exercise
Price
|
Weighted
Average Remaining
Life
|
Number
Exercisable
|
Weighted
Average
Exercise
Price
|
|||||||||||
(in
years)
|
||||||||||||||||
$1.82-$10.04
|
2,139,940
|
$
|
8.47
|
1.84
|
2,139,155
|
$
|
8.47
|
|||||||||
10.05
- 15.92
|
1,633,160
|
15.62
|
4.08
|
1,633,160
|
15.62
|
|||||||||||
15.93
- 18.48
|
1,968,993
|
18.40
|
6.10
|
660,208
|
18.25
|
|||||||||||
18.49
- 23.39
|
1,940,139
|
22.35
|
3.82
|
1,929,349
|
22.36
|
|||||||||||
23.40
- 25.26
|
1,017,826
|
24.21
|
5.36
|
1,010,642
|
24.20
|
|||||||||||
25.27
- 25.29
|
1,680,455
|
25.29
|
8.25
|
16,662
|
25.29
|
|||||||||||
25.30
- 27.05
|
2,284,560
|
26.76
|
7.15
|
733,157
|
26.25
|
|||||||||||
27.06
- 27.15
|
1,991,797
|
27.15
|
5.25
|
1,991,797
|
27.15
|
|||||||||||
27.16
- 36.10
|
1,292,367
|
29.53
|
6.53
|
907,584
|
29.39
|
|||||||||||
36.11
- 37.06
|
32,047
|
37.06
|
9.25
|
0
|
0.00
|
|||||||||||
$1.82-$37.06
|
15,981,284
|
$
|
21.58
|
5.31
|
11,021,714
|
$
|
20.30
|
13
The
aggregate pre-tax intrinsic value of options outstanding and options exercisable
at December 31, 2006 was $177.9 million and $136.8 million, respectively.
The
aggregate pre-tax intrinsic values were calculated based on the closing price
of
the Company’s common stock of $32.70 on December 29, 2006.
The
weighted average fair values per share of stock options granted in the nine
months ended December 31, 2006 was $11.95. There were no stock options
granted for the three months ended December 31, 2006.
The
weighted average fair values per share of stock options granted in connection
with the Company’s stock incentive plans in the three months ended December 31,
2005 were estimated utilizing the following assumptions:
Three
Months Ended December 31, 2005
|
||||
Expected
life (in years)
|
5.20
|
|||
Volatility
|
43
|
%
|
||
Risk-free
interest rate
|
4.40
|
%
|
||
Dividend
yield
|
2.36
|
%
|
Employee
Stock Purchase Plan
The
Company has an employee stock purchase plan and an international employee
stock
purchase plan (the “Purchase Plans”) for all eligible employees. Under the
Purchase Plans, employees may purchase shares of the Company’s common stock at
six-month intervals at 85% of fair market value (calculated in the manner
provided in the plan). Employees purchase such stock using payroll deductions,
which may not exceed 10% of their total cash compensation. The Purchase Plans
impose certain limitations upon an employee’s right to acquire common stock,
including the following: (i) no employee may purchase more than 7,500 shares
of
common stock on any purchase date and (ii) no employee may be granted rights
to
purchase more than $25,000 of common stock for each calendar year in which
such
rights are at any time outstanding. At December 31, 2006, 3.6 million
shares were available for future issuance under the Purchase Plans. The Company
issued 204,888 shares under the Purchase Plans in the nine months ended December
31, 2006.
The
weighted average fair values per share of stock purchased in connection with
the
Company’s stock purchase plan have been estimated using the following
assumptions:
Three
Months Ended December 31,
|
|||||||
2006
|
2005
|
||||||
Expected
life (in years)
|
0.50
|
0.50
|
|||||
Volatility
|
29
|
%
|
43
|
%
|
|||
Risk-free
interest rate
|
5.15
|
%
|
4.40
|
%
|
|||
Dividend
yield
|
3.50
|
%
|
2.36
|
%
|
(11)
|
Net
Income Per Share
|
The
following table sets forth the computation of basic and diluted net income
per
share (in thousands, except per share amounts):
14
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Net
income
|
$
|
72,849
|
$
|
40,124
|
$
|
229,321
|
$
|
166,801
|
|||||
Weighted
average common shares outstanding
|
215,710
|
210,836
|
214,603
|
209,556
|
|||||||||
Dilutive
effect of stock options
|
5,210
|
4,831
|
5,234
|
4,737
|
|||||||||
Weighted
average common and potential common shares outstanding
|
220,920
|
215,667
|
219,837
|
214,293
|
|||||||||
Basic
net income per common share
|
$
|
0.34
|
$
|
0.19
|
$
|
1.07
|
$
|
0.80
|
|||||
Diluted
net income per common share
|
$
|
0.33
|
$
|
0.19
|
$
|
1.04
|
$
|
0.78
|
(12)
|
Stock
Repurchase
|
On
April
22, 2004, the Company announced that its Board of Directors had authorized
the
Company to purchase up to 2.5 million shares of its common stock in the open
market or in privately negotiated transactions. As of December 31, 2006,
the
Company had repurchased 1,004,834 shares under this authorization. As of
December 31, 2006, all of the purchased shares were used to fund stock option
exercises and purchases under the Company’s employee stock purchase plans. On
October 25, 2006, the Company announced that its Board of Directors had
authorized the repurchase of up to an additional 10 million shares of its
common stock in the open market or in privately negotiated transactions.
The
timing and amount of future repurchases will depend upon market conditions,
interest rates and corporate considerations.
(13)
|
Dividends
|
On
October 28, 2002, the Company announced that its Board of Directors had approved
and instituted a quarterly cash dividend on its common stock. A quarterly
cash
dividend of $0.25 per share was paid on November 22, 2006 in the aggregate
amount of $54.0 million. A quarterly cash dividend of $0.265 per share was
declared on January 31, 2007 and will be paid on February 28, 2007 to
shareholders of record as of February 14, 2007. The Company expects the February
2007 payment of its quarterly cash dividend to be approximately
$57.4 million.
This
report, including “Part I - Item 2
Management’s Discussion and Analysis of Financial Condition and Results of
Operations” and “Part II - Item 1A Risk Factors” contains certain
forward-looking statements that involve risks and uncertainties, including
statements regarding our strategy, financial performance and revenue sources.
We
use words such as “anticipate,” “believe,” “plan,” “expect,” “future,” “intend”
and similar expressions to identify forward-looking statements. Our actual
results could differ materially from the results anticipated in these
forward-looking statements as a result of certain factors including those
set
forth under “Risk Factors,” beginning at page 31
and
elsewhere in this Form 10-Q.
Although
we believe that the expectations reflected in the forward-looking statements
are
reasonable, we cannot guarantee future results, levels of activity, performance
or achievements. You should not place undue reliance on these forward-looking
statements. We disclaim any obligation to update information contained in
any
forward-looking statement. These forward-looking statements include, without
limitation, statements regarding the following:
·
|
The
effects and amount of competitive pricing pressure on our product
lines;
|
·
|
Our
ability to moderate future average selling price
declines;
|
·
|
The
effect of product mix on gross
margin;
|
·
|
The
amount of changes in demand for our products and those of our
customers;
|
·
|
The
level of orders that will be received and shipped within a
quarter;
|
·
|
The
effect that distributor and customer inventory holding patterns
will have
on us;
|
·
|
Our
belief that customers recognize our products and brand name and
use
distributors as an effective supply
channel;
|
15
·
|
Our
belief that our direct sales personnel combined with out distributors
provide an effective means of reaching our customer
base;
|
·
|
Our
ability to increase the proprietary portion of our analog and interface
product lines and the effect of such an
increase;
|
·
|
The
impact of any supply disruption we may
experience;
|
·
|
Our
ability to effectively utilize our facilities at appropriate capacity
levels and anticipated costs;
|
·
|
That
our capital expenditures over the next 12 months will provide sufficient
manufacturing capability to meet our anticipated
needs;
|
·
|
That
manufacturing costs will be reduced by transition to advanced process
technologies;
|
·
|
Our
ability to absorb fixed costs, labor and other direct manufacturing
costs;
|
·
|
Our
ability to maintain manufacturing
yields;
|
·
|
Continuing
our investments in new and enhanced
products;
|
·
|
The
ability to attract and retain qualified
personnel;
|
·
|
The
cost effectiveness of using our own assembly and test
operations;
|
·
|
Our
anticipated level of capital
expenditures;
|
·
|
Continuing
to receive patents on our
inventions;
|
·
|
Continuation
of quarterly cash dividends;
|
·
|
The
sufficiency of our existing sources of
liquidity;
|
·
|
The
impact of seasonality on our
business;
|
·
|
Expected
impact of SFAS 123R on our
business;
|
·
|
Input
assumptions made in our estimate of the fair value of employee
stock
options and employee stock purchase rights not limited to the dividend
yield, life expectancy, volatility, forfeiture rate, and risk-free
rate of
return;
|
·
|
That
the resolution and costs of legal actions will not harm our
business;
|
·
|
That
the idling of assets will not impair the value of such
assets;
|
·
|
Our
expectation to pay-down short-term
borrowings;
|
·
|
The
recoverability of our deferred tax
assets;
|
·
|
The
adequacy of our tax reserves to offset any potential tax
liabilities;
|
·
|
Our
belief that the expiration of any tax holidays will not have a
material
impact;
|
·
|
The
ability to obtain title to land underlying our Thailand facility,
its fair
value and adequacy of associated
reserves;
|
·
|
The
accuracy of our estimates of the useful life and values of our
property
and equipment;
|
·
|
Our
ability to obtain intellectual property
licenses;
|
·
|
The
level of risk we are exposed to for product liability
claims;
|
·
|
The
amount of labor unrest, political instability, governmental interference
and changes in general economic conditions that we
experience;
|
·
|
The
effect of changes in market interest rates on income and/or cash
flows;
|
·
|
The
effect of fluctuations in currency
rates;
|
·
|
Timing
and amount of repurchases of common
stock;
|
·
|
Availability
of financing on acceptable terms;
and
|
·
|
Costs
of compliance with governmental regulations such as Section 404
of
Sarbanes-Oxley.
|
We
begin
our Management’s Discussion and Analysis of Financial Condition and Results of
Operations (MD&A) with a summary of Microchip’s overall business strategy to
give the reader an overview of the goals of our business and the overall
direction of our business and products. This is followed by a discussion
of the
Critical Accounting Policies and Estimates that we believe are important
to
understanding the assumptions and judgments incorporated in our reported
financial results. We then discuss our Results of Operations for the three
and
nine months ended December 31, 2006 compared to the three and nine months
ended
December 31, 2005. We then provide an analysis of changes in our balance
sheet
and cash flows, and discuss our financial
16
commitments
in sections titled “Liquidity and Capital Resources,” “Contractual Obligations”
and “Off-Balance Sheet Arrangements.”
Strategy
Our
goal
is to be a worldwide leader in providing specialized semiconductor products
for
a wide variety of embedded control applications. Our strategic focus is on
embedded control products, which include microcontrollers, high-performance
linear and mixed signal devices, power management and thermal management
devices, and complementary microperipheral products including interface devices,
Serial EEPROMs, and our patented KeeLoq security
devices. We provide highly cost-effective embedded control products that
also
offer the advantages of small size, high performance, low voltage/power
operation and ease of development, enabling timely and cost-effective embedded
control product integration by our customers.
Our
manufacturing operations include wafer fabrication and assembly and test.
The
ownership of our manufacturing resources is an important component of our
business strategy, enabling us to maintain a high level of manufacturing
control
resulting in us being one of the lowest cost producers in the embedded control
industry. By owning our wafer fabrication facilities and much of our assembly
and test operations, and by employing statistical
process control techniques, we have been able to achieve and maintain high
production yields. Direct control over manufacturing resources allows us
to
shorten our design and production cycles. This control also allows us to
capture
the wafer manufacturing and a portion of the assembly and test profit
margin.
We
employ
proprietary design and manufacturing processes in developing our embedded
control products. We believe our processes afford us both cost-effective
designs
in existing and derivative products and greater functionality in new product
designs. While many of our competitors develop and optimize separate processes
for their logic and memory product lines, we use a common process technology
for
both microcontroller and non-volatile memory products. This allows us to
more
fully leverage our process research and development costs and to deliver
new
products to market more rapidly. Our engineers utilize advanced computer-aided
design (CAD) tools and software to perform circuit design, simulation and
layout, and our in-house photomask and wafer fabrication facilities enable
us to
rapidly verify design techniques by processing test wafers quickly and
efficiently.
We
are
committed to continuing our investment in new and enhanced products, including
development systems, and in our design and manufacturing process technologies.
We believe these investments are significant factors in maintaining our
competitive position. Our current research and development activities focus
on
the design of new microcontrollers, digital signal controllers, ASSPs, memory
and mixed-signal products, new development systems, software and
application-specific software libraries. We are also developing new design
and
process technologies to achieve further cost reductions and performance
improvements in existing products.
We
market
our products worldwide primarily through a network of direct sales personnel
and
distributors. Our distributors focus primarily on servicing the product and
technical support requirements of a broad base of diverse customers. We believe
that our direct sales personnel combined with our distributors provide an
effective means of reaching this broad and diverse customer base. Our direct
sales force focuses primarily on major strategic accounts in three geographical
markets: the Americas, Europe and Asia. We currently maintain sales and support
centers in major metropolitan areas in North America, Europe and Asia. We
believe that a strong technical service presence is essential to the continued
development of the embedded control market. Many of our field sales engineers
(FSEs), field application engineers (FAEs), and sales management have technical
degrees and have been previously employed in an engineering environment.
We
believe that the technical knowledge of our sales force is a key competitive
advantage in the sale of our products. The primary mission of our FAE team
is to
provide technical assistance to strategic accounts and to conduct periodic
training sessions for FSEs and distributor sales teams. FAEs also frequently
conduct technical seminars in major cities around the world, and work closely
with our distributors to provide technical assistance and end-user
support.
17
Critical
Accounting Policies and Estimates
General
Our
discussion and analysis of Microchip’s financial condition and results of
operations is based upon our Consolidated Financial Statements, which have
been
prepared in accordance with accounting principles generally accepted in the
United States of America. We review the accounting policies we use in reporting
our financial results on a regular basis. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses and related disclosure
of
contingent liabilities. On an ongoing basis, we evaluate our estimates,
including those related to revenue recognition, share-based compensation,
inventories, income taxes, property plant and equipment, impairment of property,
plant and equipment and litigation. We base our estimates on historical
experience and on various other assumptions that are believed to be reasonable
under the circumstances, the results of which form the basis for making
judgments about the carrying value of assets and liabilities that are not
readily apparent from other sources. Results may differ from these estimates
due
to actual outcomes being different from those on which we based our assumptions.
We review these estimates and judgments on an ongoing basis. We believe the
following critical accounting policies affect our more significant judgments
and
estimates used in the preparation of our consolidated financial statements.
We
also have other policies that we consider key accounting policies, such as
our
policy regarding revenue recognition to OEMs; however, we do not believe
these
policies require us to make estimates or judgments that are as difficult
or
subjective as our policies described below.
Revenue
Recognition
-
Distributors
Our
distributors worldwide have broad rights to return products and price protection
rights, so we defer revenue recognition until the distributor sells the product
to their customers. We reduce product pricing through price protection based
on
market conditions, competitive considerations and other factors. Price
protection is granted to distributors on the inventory that they have on
hand at
the date the price protection is offered. When we reduce the price of our
products, it allows the distributor to claim a credit against its outstanding
accounts receivable balances based on the new price of the inventory it has
on
hand as of the date of the price reduction. There is no revenue impact to
us
from the price protections. We also grant certain credits to our distributors.
The credits are granted to the distributors on specially identified pieces
of
the distributors’ business to allow them to earn a competitive gross margin on
the sale of our products to their end customers. The credits are on a per
unit
basis and are not given to the distributor until they provide documentation
of
the sale to their end customer. The effect of granting these credits establishes
the net selling price from us to our distributors for the product and results
in
the net revenue recognized by us when the product is sold by the distributors
to
their end customers. Upon our shipment to distributors, amounts billed are
included as accounts receivable, inventory is relieved, and the sale and
the
gross margin are deferred and are reflected as a current liability until
the
product is sold by the distributor to their customers.
Share-based
Compensation
In
the
first quarter of fiscal 2007, we adopted SFAS 123R, which requires the
measurement at fair value and recognition of compensation expense for all
share-based payment awards, including grants of employee stock options, RSUs
and
employee stock purchase rights, to be recognized in our financial statements
based on their respective grant date fair values. Total share-based compensation
during the nine months ended December 31, 2006 was $23.0 million, of which
$18.1 million was reflected in operating expenses, $1.6 million was reflected
in
cost of goods sold and $3.3 million was capitalized to
inventory.
Determining
the appropriate fair-value model and calculating the fair value of share-based
awards at the date of grant requires judgment. We use the Black-Scholes option
pricing model to estimate the fair value of employee stock options and rights
to
purchase shares under stock participation plans, consistent with the provisions
of SFAS 123R. Option pricing models, including the Black-Scholes model,
also require the use of input assumptions, including expected volatility,
expected life, expected dividend rate, and expected risk-free rate
18
of
return. We use a blend of historical and implied volatility based on options
freely traded in the open market as we believe this is more reflective of
market
conditions and a better indicator of expected volatility than using purely
historical volatility. The expected life of the awards is based on historical
and other economic data trended into the future. The risk-free interest rate
assumption is based on observed interest rates appropriate for the terms
of our
awards. The dividend yield assumption is based on our history and expectation
of
future dividend payouts. The fair value of our RSUs is based on the fair
market
value of our common stock on the date of grant discounted for expected future
dividends. SFAS 123R requires us to develop an estimate of the number of
share-based awards which will be forfeited due to employee turnover. Quarterly
changes in the estimated forfeiture rate can have a significant effect on
reported share-based compensation, as the effect of adjusting the rate for
all
expense amortization after April 1, 2006 is recognized in the period the
forfeiture estimate is changed. If the actual forfeiture rate is higher than
the
estimated forfeiture rate, then an adjustment is made to increase the estimated
forfeiture rate, which will result in a decrease to the expense recognized
in
the financial statements. If the actual forfeiture rate is lower than the
estimated forfeiture rate, then an adjustment is made to decrease the estimated
forfeiture rate, which will result in an increase to the expense recognized
in
the financial statements. If forfeiture adjustments
are made, they would affect our gross margin, research and development expenses,
and selling, general, administrative expenses. The effect of forfeiture
adjustments in the first nine months of fiscal 2007 was immaterial.
We
evaluate the assumptions used to value our awards on a quarterly basis. If
factors change and we employ different assumptions, share-based compensation
expense may differ significantly from what we have recorded in the past.
If
there are any modifications or cancellations of the underlying unvested
securities, we may be required to accelerate, increase or cancel any remaining
unearned share-based compensation expense. Future share-based compensation
expense and unearned share-based compensation will increase to the extent
that
we grant additional equity awards to employees or we assume unvested equity
awards in connection with acquisitions. Had we adopted SFAS 123R in prior
periods, the magnitude of the impact of that standard on our results of
operations would have approximated the impact of SFAS 123 assuming the
application of the Black-Scholes option pricing model as described in the
disclosure of pro forma net income and pro forma net income per share
in Note 10 to our Unaudited Condensed Consolidated Financial
Statements.
Inventories
Inventories
are valued at the lower of cost or market using the first-in, first-out method.
We write down our inventory for estimated obsolescence or unmarketable inventory
in an amount equal to the difference between the cost of inventory and the
estimated market value based upon assumptions about future demand and market
conditions. If actual market conditions are less favorable than those we
projected, additional inventory write-downs may be required. Inventory
impairment charges establish a new cost basis for inventory and charges are
not
subsequently reversed to income even if circumstances later suggest that
increased carrying amounts are recoverable. In estimating our inventory
obsolescence, we primarily evaluate estimates of demand over a 12-month period
and record impairment charges for inventory on hand in excess of the estimated
12-month demand.
Income
Taxes
As
part
of the process of preparing our consolidated financial statements, we are
required to estimate our income taxes in each of the jurisdictions in which
we
operate. This process involves estimating our actual current tax exposure
together with assessing temporary differences resulting from differing treatment
of items for tax and accounting purposes. These differences result in deferred
tax assets and liabilities, which are included within our consolidated balance
sheet. We must then assess the likelihood that our deferred tax assets will
be
recovered from future taxable income within the relevant jurisdiction and
to the
extent we believe that recovery is not likely, we must establish a valuation
allowance. We have not provided for a valuation allowance because we believe
that it is more likely than not that our deferred tax assets will be recovered
from future taxable income. Should we
19
determine
that we would not be able to realize all or part of our net deferred tax
asset
in the future, an adjustment to the deferred tax asset would be charged to
income in the period such determination was made. At December 31, 2006, our
gross deferred tax asset was $69.0 million.
Various
taxing authorities in the United States and other countries in which we do
business are increasing their scrutiny of various tax structures employed
by
businesses. Companies of our size and complexity are regularly audited by
the
taxing authorities in the jurisdictions in which they conduct significant
operations. We are currently under audit by the United States Internal Revenue
Service (“IRS”) for our fiscal years ended March 31,
1998,
1999, 2000 and 2001. As part of this ongoing audit, the IRS has proposed
certain
adjustments related to positions reflected on these returns. The IRS has
issued
formal assessments for these adjustments. We do not agree with these adjustments
and are appealing these assessments. We recognize liabilities for anticipated
tax audit issues in the United States and other tax jurisdictions based on
our
estimate of whether, and the extent to which, additional tax payments are
probable. We believe that we maintain adequate tax reserves to offset any
potential tax liabilities that may arise upon final resolution of the pending
audit through either settlement or the appeals process with the IRS. The
IRS is
also currently auditing our fiscal years ended March 31, 2002, 2003 and 2004.
We
believe that we maintain adequate tax reserves to offset any potential tax
liabilities that may arise upon these and other audits in the United States
and
other countries in which we do business. If such amounts ultimately prove
to be
unnecessary, the resulting reversal of such reserves would result in tax
benefits being recorded in the period the reserves are no longer deemed
necessary. If such amounts ultimately prove to be less than
an
ultimate assessment, a future charge to expense would be recorded in the
period
in which the assessment is determined.
Property,
Plant & Equipment
Property,
plant and equipment are stated at cost. Major renewals and improvements are
capitalized, while maintenance and repairs are expensed when incurred. At
December 31, 2006, the carrying value of our property and equipment totaled
$625.0 million, which represents 27.4% of our total assets. This carrying
value reflects the application of our property and equipment accounting
policies, which incorporate estimates, assumptions and judgments relative
to the
useful lives of our property and equipment. Depreciation is provided on a
straight-line basis over the estimated useful lives of the related assets,
which
range from five to seven years on manufacturing equipment and approximately
30
years on buildings.
We
began
production activities at Fab 4 on October 31, 2003. We began to depreciate
the
Fab 4 assets as they were placed in service for production purposes. As of
December 31, 2006, all of the buildings and supporting facilities were being
depreciated as well as the manufacturing equipment that had been placed in
service. All manufacturing equipment that was not being used in production
activities was maintained in projects in process and is not being depreciated
until it is placed into service since management believes there will be no
change to its utility from the present time until it is placed into productive
service. The lives to be used for depreciating this equipment at Fab 4 will
be
evaluated at such time as the assets are placed in service. We do not believe
that the temporary idling of such assets has impaired the estimated life
or
carrying values of the underlying assets.
On
March
31, 2005, we changed the classification of Fab 3 from an asset held-for-sale
to
an asset held-for-future-use. Fab 3 had been on the market for over two years,
and we had not received any acceptable offers on the facility. Over that
period
of time, our business had increased significantly and over the next several
years we will need to begin planning for future wafer fabrication capacity
as a
larger percentage of Fab 4’s clean room capacity is utilized. We determined that
the appropriate action to take was to stop actively marketing the Fab 3 facility
and hold it for our future use. As a result of this change in classification,
we
had to assess the fair value of the Fab 3 asset to determine if any additional
impairment charge was required upon the change in classification from
“held-for-sale” to “held-for-future-use” under SFAS No. 144. We performed a
discounted cash flow analysis of the Fab 3 asset based on various financial
projections in developing the fair value estimate given that it was the best
available valuation technique for the asset. The discounted cash flow analysis
confirmed the carrying value of the Fab 3 asset at March 31, 2005 was not
in
excess of its fair value. If indicators of impairment for the
20
Fab
3
assets arise in the future, we will determine if the sum of the estimated
undiscounted cash flows attributable to the assets in question are less than
their carrying value. If less, we would recognize an impairment loss on the
excess of the carrying amount of the assets over their respective fair values.
We began to depreciate the Fab 3 asset in April 2005.
The
estimates, assumptions and judgments we use in the application of our property
and equipment policies reflect both historical experience and expectations
regarding future industry conditions and operations. The use of different
estimates, assumptions and judgments regarding the useful lives of our property
and equipment and expectations regarding future industry conditions and
operations, could result in materially different carrying values of assets
and
results of operations.
We
do not
currently hold title to the land on which our Thailand facility resides.
The
land is subject to a bankruptcy relating to the seller of the land. We have
provided reserves that we estimate will be adequate to obtain full title.
Such
reserves are set at the estimated fair value of the land. However, timing
of the
resolution is difficult to predict and the ultimate amount to be paid could
change.
Impairment
of Property, Plant and Equipment
We
assess
whether indicators of impairment of long-lived assets are present. If such
indicators are present, we determine whether the sum of the estimated
undiscounted cash flows attributable to the assets in question is less than
their carrying value. If less, we recognize an impairment loss based on the
excess of the carrying amount of the assets over their respective fair values.
Fair value is determined by discounted future cash flows, appraisals or other
methods. If the assets determined to be impaired are to be held and used,
we
recognize an impairment loss through a charge to our operating results to
the
extent the present value of anticipated net cash flows attributable to the
asset
are less than the asset’s carrying value, which we depreciate over the remaining
estimated useful life of the asset. We may incur impairment losses, or
additional losses on already impaired assets, in future periods if factors
influencing our estimates change.
Litigation
Our
current estimated range of liability related to pending litigation is based
on
the probable loss of claims for which we can estimate the amount and range
of
loss. Recorded reserves were not significant at December 31, 2006.
Because
of the uncertainties related to both the probability of loss and the amount
and
range of loss on our pending litigation, we are unable to make a reasonable
estimate of the liability that could result from an unfavorable outcome.
As
additional information becomes available, we will assess the potential liability
related to our pending litigation and revise our estimates. Revisions in
our
estimates of the potential liability could materially impact our results
of
operation and financial position.
Results
of Operations
The
following table sets forth certain operational data as a percentage of net
sales
for the periods indicated:
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
||||||||||||
2006
|
2005
|
2006
|
2005
|
||||||||||
Net
sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Cost
of sales
|
40.4
|
%
|
40.3
|
%
|
39.8
|
%
|
40.9
|
%
|
|||||
Gross
profit
|
59.6
|
%
|
59.7
|
%
|
60.2
|
%
|
59.1
|
%
|
|||||
Research
and development
|
11.2
|
%
|
10.0
|
%
|
10.9
|
%
|
10.3
|
%
|
|||||
Selling,
general and administrative
|
16.0
|
%
|
13.7
|
%
|
15.7
|
%
|
14.0
|
%
|
|||||
Operating
income
|
32.5
|
%
|
36.0
|
%
|
33.6
|
%
|
34.8
|
%
|
21
Net
Sales
We
operate in one industry segment and engage primarily in the design, development,
manufacture and marketing of semiconductor products. We sell our products
to
distributors and original equipment manufacturers, referred to as OEMs, in
a
broad range of market segments, perform ongoing credit evaluations of our
customers and generally require no collateral.
Our
net
sales for the quarter ended December 31, 2006 were $251.0 million, a
decrease of 6.3% from the previous quarter’s sales of $267.9 million, and an
increase of 6.9% from net sales of $234.9 million in the quarter ended December
31, 2005. Our net sales for the nine months ended December 31, 2006 were
$781.5
million, an increase of 14.8% from net sales of $680.7 million in the nine
months ended December 31, 2005. The changes in net sales in these periods
resulted primarily from changes in market conditions across all of our product
lines. Average selling prices for our products were down approximately 2%
for
the three-month period ended December 31, 2006 and up approximately 1% for
the
nine-month period ended December 31, 2006 over the corresponding periods
of the
previous fiscal year. The number of units of our products sold were up
approximately 8% and 14% for the three and nine-month periods ended December
31,
2006 over the corresponding periods of the previous fiscal year. The average
selling prices and the unit volumes of our sales are impacted by the mix
of our
products sold. Key factors in achieving the amount of net sales during the
three
and nine-month periods ended December 31, 2006 include:
·
|
continued
market share gains;
|
·
|
increasing
semiconductor content in our customers’
products;
|
·
|
customers’
increasing needs for the flexibility offered by our programmable
solutions;
|
·
|
our
new product offerings that have increased our served available
market;
|
·
|
increasing
demand for our products;
|
·
|
economic
conditions in the markets we serve;
and
|
·
|
inventory
holding patterns of our customers.
|
We
recognize revenue from product sales upon shipment to OEMs. Under our shipping
terms, legal title passes to the customer upon shipment from Microchip.
We have
no post-shipment obligations. Distributors generally have broad rights
to return
products and price protection rights, so we defer revenue recognition until
the
distributors sell the product to their customers. Upon shipment, amounts
billed
to distributors are included in accounts receivable, inventory is relieved,
the
sale is deferred and the gross margin is reflected as a current liability
until
the product is sold by the distributors to their customers.
Sales
by
product line for the three and nine months ended December 31, 2006 and December
31, 2005 were as follows (dollars in thousands):
Three
Months Ended
December
31,
(unaudited)
|
Nine
Months Ended
December
31,
(unaudited)
|
||||||||||||||||||||||||
2006
|
%
|
2005
|
%
|
2006
|
%
|
2005
|
%
|
||||||||||||||||||
Microcontrollers
|
$
|
200,073
|
79.7
|
%
|
$
|
186,235
|
79.3
|
%
|
$
|
626,167
|
80.1
|
%
|
$
|
540,817
|
79.4
|
%
|
|||||||||
Memory
products
|
30,105
|
12.0
|
%
|
31,323
|
13.3
|
%
|
92,843
|
11.9
|
%
|
93,907
|
13.8
|
%
|
|||||||||||||
Analog
and interface products
|
20,826
|
8.3
|
%
|
17,338
|
7.4
|
%
|
62,485
|
8.0
|
%
|
45,997
|
6.8
|
%
|
|||||||||||||
Total
sales
|
$
|
251,004
|
100.0
|
%
|
$
|
234,896
|
100.0
|
%
|
$
|
781,495
|
100.0
|
%
|
$
|
680,721
|
100.0
|
%
|
22
Microcontrollers
Our
microcontroller product line represents the largest component of our total
net
sales. Microcontrollers and associated application development systems accounted
for approximately 79.7% of our total net sales for the three-month period
ended
December 31, 2006 and approximately 80.1% of
our
total net sales for the nine-month period ended December 31, 2006 compared
to
approximately 79.3% of our total net sales for the three-month period ended
December 31, 2005 and approximately 79.4% of our total net sales for the
nine-month period ended December 31, 2005.
Net
sales
of our microcontroller products increased approximately 7.4% in the three-month
period ended December 31, 2006 and 15.8% in the nine-month period ended December
31, 2006 compared to the three and nine-month periods ended December 31,
2005.
These sales increases were primarily due to increased demand for our
microcontroller products in end markets, driven principally by market share
gains and those factors described on page 22
above.
The end markets that we serve include the consumer, automotive, industrial
control, communications and computing markets.
Historically,
average selling prices in the semiconductor industry decrease over the life
of
any particular product. The overall average selling prices of our
microcontroller products have remained relatively constant over time due
to the
proprietary nature of these products. We have experienced, and expect to
continue to experience, moderate pricing pressure in certain microcontroller
product lines, primarily due to competitive conditions. We have been able
to in
the past, and expect to be able to in the future, moderate average selling
price
declines in our microcontroller product lines by introducing new products
with
more features and higher prices. We may be unable to maintain average selling
prices for our microcontroller products as a result of increased pricing
pressure in the future, which would adversely affect our operating
results.
Memory
Products
Sales
of
our memory products accounted for approximately 12.0% of our total net sales
for
the three-month period ended December 31, 2006 and 11.9% of our total net
sales
for the nine-month period ended December 31, 2006 compared to approximately
13.3% of our total net sales for the three-month period ended December 31,
2005
and 13.8% of our total net sales in the nine-month period ended December
31,
2005.
Net
sales
of our memory products decreased approximately 3.9% in the three-month period
ended December 31, 2006 compared to the three-month period ended December
31,
2005. Net sales of our memory products decreased approximately 1.1% in the
nine-month period ended December 31, 2006 compared to the nine-month period
ended December 31, 2005. These sales decreases were driven by market share
gains
and customer demand conditions within the Serial EEPROM market, which products
comprise substantially all of our memory product net sales.
Serial
EEPROM product pricing has historically been cyclical in nature, with steep
price declines followed by periods of relative price stability, driven by
changes in industry capacity at different stages of the business cycle. We
have
experienced, and expect to continue to experience, varying degrees of
competitive pricing pressures in our Serial EEPROM products. We may be unable
to
maintain the average selling prices of our Serial EEPROM products as a result
of
increased pricing pressure in the future, which could adversely affect our
operating results.
Analog
and Interface Products
Sales
of
our analog and interface products accounted for approximately 8.3% of our
total
net sales for the three-month period ended December 31, 2006 and 8.0% of
our
total net sales for the nine-month period ended December 31, 2006 compared
to
approximately 7.4% of our total net sales for the three-month period ended
December 31, 2005 and 6.8% of our total net sales for the nine-month period
ended December 31, 2005.
23
Net
sales
of our analog and interface products increased approximately 20.1% in the
three-month period ended December 31, 2006 and 35.8% in the nine-month period
ended December 31, 2006 compared to the three and nine-month periods ended
December 31, 2005. These sales increases in our analog and interface products
were driven by market share gains and supply and demand conditions within
the
analog and interface market.
Analog
and interface products can be proprietary or non-proprietary in nature.
Currently, we consider more than half of our analog and interface product
mix to
be proprietary in nature, where prices are relatively stable, similar to
the
pricing stability experienced in our microcontroller products. The
non-proprietary portion of our analog and interface business will experience
price fluctuations, driven primarily by the current supply and demand for
those
products. We may be unable to maintain the average selling prices of our
analog
and interface products as a result of increased pricing pressure in the future,
which would adversely affect our operating results. We anticipate the
proprietary portion of our analog and interface products will increase over
time.
Turns
Orders
Our
net
sales in any given quarter depend upon a combination of shipments from backlog
and orders received in that quarter for shipment in that quarter, which we
refer
to as turns orders. Historically, we have proven our ability to respond quickly
to customer orders as part of our competitive strategy, resulting in customers
placing orders with short delivery schedules. Shorter lead times generally
mean
that turns orders as a percentage of our business are relatively high in
any
particular quarter and reduce our backlog visibility on future product
shipments. Turns orders correlate to overall semiconductor industry conditions
and product lead times. Turns orders are difficult to predict, and we may
not
experience the combination of turns orders and shipments from backlog in
a
quarter that would be sufficient to achieve anticipated net sales. If we
do not
achieve a sufficient level of turns orders in a particular quarter, our net
sales and operating results may suffer.
Distribution
Distributors
accounted for approximately 65% of our net sales in the nine-month period
ended
December 31, 2006 and approximately 64% of our net sales in the nine-month
period ended December 31, 2005.
Our
two
largest distributors accounted for approximately 21% of our net sales in
the
nine-month period ended December 31, 2006 and approximately 24% of our net
sales
in the nine-month period ended December 31, 2005.
Generally,
we do not have long-term agreements with our distributors and we, or our
distributors, may terminate our relationships with each other with little
or no
advanced notice. The loss of, or the disruption in the operations of, one
or
more of our distributors could reduce our future net sales in a given quarter
and could result in an increase in inventory returns.
At
December 31, 2006, our distributors were maintaining an average of approximately
1.9 months of inventory of our products. Over the past three fiscal years,
the
months of inventory maintained by our distributors have fluctuated between
approximately 1.9 and 2.8 months. Thus, inventory levels at our distributors
are
at the low end of the range we have experienced over the last three years.
As we
recognize revenue based on sell through for all of our distributors, we do
not
believe that inventory holding patterns at our distributors will materially
impact our net sales.
Sales
by Geography
Sales
by
geography for the three
and
nine-month periods ended December 31, 2006 and December 31, 2005 were as
follows
(dollars in thousands):
24
Three
Months Ended
December
31,
(unaudited)
|
Nine
Months Ended
December
31,
(unaudited)
|
||||||||||||||||||||||||
2006
|
%
|
2005
|
%
|
2006
|
%
|
2005
|
%
|
||||||||||||||||||
Americas
|
$
|
70,072
|
27.9
|
%
|
$
|
66,143
|
28.2
|
%
|
$
|
217,280
|
27.8
|
%
|
$
|
194,085
|
28.5
|
%
|
|||||||||
Europe
|
70,749
|
28.2
|
%
|
60,105
|
25.6
|
%
|
218,348
|
27.9
|
%
|
184,293
|
27.1
|
%
|
|||||||||||||
Asia
|
110,183
|
43.9
|
%
|
108,648
|
46.2
|
%
|
345,867
|
44.3
|
%
|
302,343
|
44.4
|
%
|
|||||||||||||
Total
sales
|
$
|
251,004
|
100.0
|
%
|
$
|
234,896
|
100.0
|
%
|
$
|
781,495
|
100.0
|
%
|
$
|
680,721
|
100.0
|
%
|
Our
sales
to foreign customers have been predominately in Asia and Europe, which we
attribute to the manufacturing strength in those areas for automotive,
communications, computing, consumer and industrial control products. Americas
sales include sales to customers in the United States, Canada, Central America
and South America. Sales to customers in Asia have increased over time due
to
many of our customers transitioning their manufacturing operations to Asia
and
growth in demand from the emerging Asian market.
Sales
to
foreign customers accounted for approximately 75% of our net sales in the
three-month period ended December 31, 2006 and 74% of our net sales in the
three-month period ended December 31, 2005. Sales to foreign customers accounted
for 74% of our net sales in the nine-month period ended December 31, 2006
and
73% of our net sales in the nine-month period ended December 31, 2005.
Substantially all of our foreign sales are U.S. dollar denominated.
Gross
Profit
Our
gross
profit was $149.7 million in the three months ended December 31, 2006, and
$140.3 million in the three months ended December 31, 2005. Our gross profit
was
$470.2 million in the nine months ended December 31, 2006, and $402.3 million
in
the nine months ended December 31, 2005. Gross profit as a percent of sales
was
59.6% in the three months ended December 31, 2006, and 59.7% in the three
months
ended December 31, 2005. Gross profit as a percent of sales was 60.2% in
the
nine months ended December 31, 2006, and 59.1% in the nine months ended December
31, 2005.
The
most
significant factors affecting our gross profit percentage in the periods
covered
by this report were:
·
|
increased
cost of sales of $1.6 million in the three months ended December
31, 2006
associated with share-based compensation expense under the SFAS
123R;
|
·
|
fluctuations
in the product mix of microcontrollers, proprietary and non-proprietary
analog products and Serial EEPROM products resulting in higher
average
selling prices for our products;
and
|
·
|
continued
cost reductions in wafer fabrication and assembly and test manufacturing
such as new manufacturing technologies and more efficient manufacturing
techniques.
|
Other
factors that impacted gross profit percentage in the periods covered by this
report include:
·
|
changes
in capacity utilization and absorption of fixed
costs;
|
·
|
gross
profit on products sold through the distribution
channel;
|
·
|
depreciation
expense as a percentage of cost of sales;
and
|
·
|
inventory
write-offs and the sale of inventory that was previously written
off.
|
During
the three-month period ended December
31, 2006, we operated at approximately 99% of our Fab 2 capacity, which is
approximately the same level of utilization from the same period of the previous
fiscal
25
year.
Our
utilization of Fab 4’s total capacity is at relatively low levels although we
are utilizing all of the installed equipment base. We expect to maintain
approximately the same levels of capacity utilization at Fab 2 and Fab 4
during the fourth quarter of fiscal 2007.
The
process technologies utilized impact our gross margins. Fab 2 currently utilizes
various manufacturing process technologies, but predominantly utilizes our
0.5
to 1.0 micron processes. At December 31, 2006, Fab 4 predominantly utilized
our
0.5 micron process technology. We continue to transition products to more
advanced process technologies to reduce future manufacturing costs. All of
our
production has been on 8-inch wafers for the periods covered by this report.
Our
overall inventory levels were $121.9 million at December 31, 2006 compared
to
$115.0 million at March 31, 2006. We had 110 days
of
inventory on our balance sheet at December 31, 2006 compared to 106 days
at
March 31, 2006 and 111 days at December 31, 2005. In the three and nine months
ended December 31, 2006, $1.7 million and $5.0 million, respectively, of
share-based compensation expense was capitalized to inventory as a result
of the
adoption of SFAS 123R. The adoption of this accounting standard adversely
impacted our gross profit in the quarter ending December 31, 2006, as the
inventory including the share-based compensation was sold.
We
anticipate that our gross margins will fluctuate over time, driven primarily
by
the overall product mix of microcontroller, analog and interface and memory
products and the percentage of net sales of each of these products in a
particular quarter, as well as manufacturing yields, fixed cost absorption,
capacity utilization levels, particularly those at Fab 4, and competitive
and
economic conditions.
At
December 31, 2006, approximately 73% of our assembly requirements were being
performed in our Thailand facility, compared to approximately 62% as of December
31, 2005. Third-party contractors located in Asia perform the balance of
our
assembly operations. Substantially all of our test requirements were being
performed in our Thailand facility as of December 31, 2006 and December 31,
2005. We believe that the assembly and test operations performed at our Thailand
facility provide us with significant cost savings when compared to third-party
contractor assembly and test costs, as well as increased control over these
portions of the manufacturing process.
We
rely
on outside wafer foundries for a small portion of our wafer fabrication
requirements.
Our
use
of third parties involves some reduction in our level of control over the
portions of our business that we subcontract. While we review the quality,
delivery and cost performance of our third-party contractors, our future
operating results could suffer if any third-party contractor is unable to
maintain manufacturing yields, assembly and test yields and costs at
approximately their current levels.
Research
and Development (R&D)
R&D
expenses for the three months ended December 31, 2006 were $28.0 million,
or 11.2% of sales, compared to $23.4 million, or 10.0% of sales, for the
three months ended December 31, 2005. R&D expenses for the nine months ended
December 31, 2006 were $85.2 million, or 10.9% of sales, compared to
$70.4 million, or 10.3% of sales, for the nine months ended December 31,
2005. We are committed to investing in new and enhanced products, including
development systems software, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. We expense all R&D costs as incurred.
R&D expenses include labor, depreciation, masks, prototype wafers, and
expenses for the development of process technologies, new packages, and software
to support new products and design environments.
R&D
expenses increased $4.7 million, or 20.0%, for the three months ended
December 31, 2006 over the same period last year. R&D expenses increased
$14.7 million, or 20.9%, for the nine months ended December 31, 2006 over
the same period last year. The primary reasons for the increases in R&D
expenses in these periods
26
were
higher labor costs as a result of expanding our internal R&D headcount,
increases in bonuses and $2.4 million and $7.2 million of share-based
compensation as a result of the adoption of SFAS 123R in the three and nine
months ended December 31, 2006, respectively.
Selling,
General and Administrative
Selling,
general and administrative expenses for the three months ended December 31,
2006
were $40.2 million,
or 16.0% of sales, compared to $32.3 million, or 13.8% of sales, for the
three
months ended December 31, 2005. Selling, general and administrative expense
for
the nine months ended December 31, 2006 were $122.5 million, or 15.7% of
sales, compared to $95.0 million, or 14.0% of sales, for the nine months
ended December 31, 2005. Selling, general and administrative expenses include
salary expenses related to field sales, marketing and administrative personnel,
advertising and promotional expenditures and legal expenses. Selling, general
and administrative expenses also include costs related to our direct sales
force
and field applications engineers who work in sales offices worldwide to
stimulate demand by assisting customers in the selection and use of our
products.
Selling,
general and administrative expenses increased $7.9 million, or 24.4%, for
the three months ended December 31, 2006 over the same period last year.
Selling, general and administrative expenses increased
$27.5 million,
or 28.9%,
for the nine
months ended December 31, 2006 over the same period last year. The primary
reasons for the increases in selling, general and administrative expenses
in
these periods were higher labor costs as a result of expanding our internal
resources involved in the technical aspect of selling our products, increases
in
bonuses and $2.8 million and $8.2 million
of share-based compensation as a result of the adoption of SFAS 123R, in
the
three and nine-month periods ended December 31, 2006, respectively.
Selling,
general and administrative expenses fluctuate over time, primarily due to
revenue and operating expense levels.
Other
Income (Expense)
Interest
income in the three and nine-month periods ended December 31, 2006 increased
from interest income in the three and nine-month periods ended December 31,
2005
as our average invested cash balances and the average interest rates on those
invested cash balances were at higher levels in the periods ended December
31,
2006 compared to the same periods in the prior fiscal year.
Provision
for Income Taxes
Provisions
for income taxes reflect tax on foreign earnings and federal and state tax
on
U.S. earnings. We had an effective tax rate of 24.0% for the three and
nine-month periods ending December 31, 2006 and December 31,
2005.
At
December 31, 2006, our gross deferred tax asset was $69.0 million. Our gross
deferred tax asset decreased by $9.6 million in the nine months ended
December 31, 2006 compared to the level at March 31, 2006, due primarily
to
increases in income, which allowed us to utilize tax credits, and changes
in
various temporary differences between our book and tax reporting. At December
31, 2006, our deferred tax liability was $13.2 million. Our gross deferred
tax liability decreased by $1.4 million in the nine months ended
December 31, 2006 compared to the level at March 31, 2006, due primarily to
changes in temporary differences in depreciation between our book and tax
reporting.
Our
Thailand manufacturing operations currently benefit from numerous tax holidays
that have been granted to us by the Thailand government based on our investments
in property, plant and equipment in Thailand. Our tax holiday periods in
Thailand expire at various times in the future. One of our Thailand tax holidays
expired in September 2006 and the expiration did not have a material impact
on
our effective tax rate. We do not expect the future expiration of any of
our tax
holiday periods in Thailand to have a material impact on our
27
effective
tax rate. Any expiration of tax holidays are expected to have a minimal impact
on our overall tax expense due to other tax holidays and an increase in income
in other taxing jurisdictions with lower statutory rates.
Liquidity
and Capital Resources
We
had
$1,264 million in cash, cash equivalents and short-term and long-term
investments at December 31, 2006, a decrease of $20.6 million from the
March 31, 2006 balance. The decrease in cash, cash equivalents and short-term
and long-term investments over this time period is primarily attributable
to a
$239.5 million pay down of short-term debt offset by cash generated from
operating activities.
Net
cash
provided from operating activities was $357.8
million
for the nine-month period ended December 31, 2006 compared to $323.1 million
for
the nine-month period ended December 31, 2005. The increase in cash flow
from
operations was primarily from increases in profitability, $19.4 million of
additional share-based compensation expenses as a result of the adoption
of SFAS
123R, changes in accounts receivable, accounts payable and accrued liability
balances, and changes in deferred income on shipments to
distributors.
During
the nine months ended December 31, 2006, net cash used in investing activities
increased $221.9 million,
to $436.8 million, from $214.9 million for the nine months ended December
31,
2005. The increase was due primarily to changes in our net purchases, sales
and
maturities of short-term and long-term investments in the nine months ended
December 31, 2006. Capital expenditures were $51.4 million in the nine-month
period ended December 31, 2006 compared to $42.8 million in the nine-month
period ended December 31, 2005.
We
enter
into hedging transactions from time to time in an attempt to reduce our exposure
to currency rate fluctuations. The amount of the hedges outstanding at December
31, 2006 were immaterial. Although none of the countries in which we conduct
significant foreign operations have had a highly inflationary economy in
the
last five years, there is no assurance that inflation rates or fluctuations
in
foreign currency rates in countries where we conduct operations will not
adversely affect our operating results in the future.
Our
level
of capital expenditures varies from time to time as a result of actual and
anticipated business conditions. Capital expenditures in the nine months
ended
December 31, 2006 were $51.4 million compared to $42.8 million for the nine
months ended December 31, 2005. Capital expenditures are primarily for the
expansion of production capacity and the addition of research and development
equipment. We currently anticipate spending approximately $60 million to
$65 million during the next 12 months to invest in equipment and facilities
to maintain, and selectively increase, capacity to meet our currently
anticipated needs.
We
expect
to finance capital expenditures through our existing cash balances and cash
flows from operations. We believe that the capital expenditures anticipated
to
be incurred over the next 12 months will provide sufficient manufacturing
capacity to meet our currently anticipated needs.
Net
cash
used in financing activities was $333.0 million for the nine months ended
December 31, 2006 compared to $19.4 million for the nine months ended December
31, 2005. Proceeds from the exercise of stock options and employee purchases
under our employee stock purchase plan were $42.3 million for the nine months
ended December 31, 2006 and $63.5 million
for the nine months ended December 31, 2005. We paid cash dividends to our
shareholders of $150.5 million in the nine months ended December 31, 2006
and $ 79.6 million
in the nine months ended December 31, 2005. During the nine months ended
December 31, 2006, we paid down $239.5 million in short-term borrowings,
resulting in a short-term borrowing balance of $29.5 million at December
31,
2006. The short-term borrowings related to transactions associated with our
repatriation of foreign earnings under the American Jobs Creation Act in
fiscal
2006. To complete the repatriation of $500 million, we initiated certain
borrowings which were collateralized against investments held in our foreign
locations. We presently expect to pay down the short-term borrowings as our
investments mature and new cash is generated in
28
the
foreign locations. Excess tax benefits from share-based payment arrangements
were $14.7 million in the nine months ended December 31, 2006.
On
April
22, 2004, our Board of Directors authorized the repurchase of 2.5 million
shares
of our common stock in the open market or in privately negotiated transactions.
As of December 31, 2006, we had repurchased 1,004,834 common shares under
this
authorization for a total of $26.6 million. As of December 31, 2006, all of
the purchased shares under the authorization were used to fund stock option
exercises and purchases under our employee stock purchase plan. On October
25,
2006, our Board of Directors authorized the repurchase of up to an additional
10 million shares of our common stock in the open market or in privately
negotiated transactions. The timing and amount of any future repurchases
will
depend upon market conditions, interest rates and corporate
considerations.
On
October 28, 2002, we announced that our Board of Directors had approved and
instituted a quarterly cash dividend on our common stock. The initial quarterly
dividend of $0.02 per share was paid on December 6, 2003 in the aggregate
amount
of $4.0 million. We have continued to pay quarterly dividends and have
increased the amount of such dividends on a regular basis. A quarterly dividend
of $0.25 per share was paid on November 22, 2006 in the aggregate amount
of
$54.0 million. A quarterly dividend of $0.265 per share was declared on
January 31, 2007 and will be paid on February 28, 2007 to shareholders of
record as of February 14, 2007. We expect the February 2007 cash dividend
to be
approximately $57.4 million. During fiscal 2006, we paid dividends in the
aggregate amount of $0.57 per
share
for a total dividend payment of $120.1 million. Since the inception of our
dividend program, we have paid aggregate dividends of $345.1
million.
We
believe that our existing sources of liquidity combined with cash generated
from
operations will be sufficient to meet our currently anticipated cash
requirements for at least the next 12 months. However, the semiconductor
industry is capital intensive. In order to remain competitive, we must
constantly evaluate the need to make significant investments in capital
equipment for both production and research and development. We may seek
additional equity or debt financing from time to time to maintain or expand
our
wafer fabrication and product assembly and test facilities, or for other
purposes. The timing and amount of any such financing requirements will depend
on a number of factors, including demand for our products, changes in industry
conditions, product mix, and competitive factors. There can be no assurance
that
such financing will be available on acceptable terms, and any additional
equity
financing would result in incremental ownership dilution to our existing
stockholders.
Contractual
Obligations
There
have not been any material changes in our contractual obligations from what
we
disclosed in our Annual Report on Form 10-K for the fiscal year ended March
31,
2006.
Off-Balance
Sheet Arrangements
As
of
December 31, 2006, we are not involved in any off-balance sheet arrangements,
as
defined in Item 303(a)(4)(ii) of SEC Regulation S-K.
Recently
Issued Accounting Pronouncements
In
July
2006, the FASB issued FASB Interpretation No. 48, “Accounting for Uncertainty in
Income Taxes” (“FIN 48”). FIN 48 is an interpretation of FASB Statement No. 109,
“Accounting for Income Taxes,” and it seeks to reduce the diversity in practice
associated with certain aspects of measurement and recognition in accounting
for
income taxes. In addition, FIN 48 requires expanded disclosure with respect
to
the uncertainty in income taxes and is effective for us as of the beginning
fiscal 2008. We are currently evaluating the impact, if any, that FIN 48
will
have on our financial statements.
29
In
September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS
157”). SFAS 157 defines fair value, establishes a framework for measuring
fair value in accordance with generally accepted accounting principles, and
expands disclosures about fair value measurements. The provisions of SFAS
157
are effective for fiscal years beginning after November 15, 2007. We are
currently evaluating the impact, if any, that SFAS 157 will have on our
financial statements.
In
September 2006, the FASB issued SFAS 158, “Employers’ Accounting for Defined
Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements
No. 87, 88, 106 and 132(R)” (“SFAS 158”) and is effective for our fiscal year
ended March 31, 2007. This standard requires companies to recognize, on a
prospective basis, the funded status of their defined benefit pension and
other
postretirement benefit plans as a net liability or asset on their balance
sheets. We are currently evaluating the impact, if any, that SFAS 158 will
have on our financial statements.
Our
investment portfolio, consisting of fixed income securities and money market
funds that we hold on an available-for-sale basis, was $1.3 billion
as of
December 31, 2006. This amount includes securities with original maturities
that
are within 90 days when acquired and are classified as cash and cash equivalents
on our balance sheet. The securities in our investment portfolio, like all
fixed
income instruments, are subject to interest rate and credit risk and will
decline in value if market interest rates increase. We have the ability to
hold
our fixed income investments until maturity and, therefore, we would not
expect
to recognize any material adverse impact in income or cash flows if market
interest rates increase. The following table provides information about our
available-for-sale securities that are sensitive to changes in interest rates.
We have aggregated our available-for-sale securities for presentation purposes
since they are all very similar in nature (dollars in thousands):
Financial
instruments mature during the fiscal year ended March 31,
|
|||||||||||||||||||
2007
|
2008
|
2009
|
2010
|
2011
|
Thereafter
|
||||||||||||||
Available-for-sale
securities
|
$
|
191,661
|
$
|
219,004
|
$
|
203,302
|
$
|
222,791
|
$
|
45,491
|
$
|
229,035
|
|||||||
Weighted-average
yield rate
|
4.96
|
%
|
3.68
|
%
|
3.85
|
%
|
4.29
|
%
|
5.76
|
%
|
5.34
|
%
|
We
have
international operations and are thus subject to foreign currency rate
fluctuations. To date, our exposure related to exchange rate volatility has
not
been significant. Approximately 99% of our sales are denominated in U.S.
dollars. At times we maintain hedges of foreign currency exposure of a net
investment in a foreign operation. We had no foreign currency hedges outstanding
as of December 31, 2006. If foreign currency rates fluctuate by 15% from
the
rates at December 31, 2006, the effect on our financial position and results
of
operation would not be material.
During
the normal course of business we are routinely subjected to a variety of
market
risks, examples of which include, but are not limited to, interest rate
movements and foreign currency fluctuations, as we discuss in this Item 3,
and
collectability of accounts receivable. We continuously assess these risks
and
have established policies and procedures to protect against the adverse effects
of these and other potential exposures. Although we do not anticipate any
material losses in these risk areas, no assurance can be made that material
losses will not be incurred in these areas in the future.
Evaluation
of Disclosure Controls and Procedures
As
of the
end of the period covered by this Quarterly Report on Form 10-Q, as required
by
paragraph (b) of Rule 13a-15 or Rule 15d-15 under the Securities Exchange
Act of
1934, as amended, we evaluated under the
30
supervision
of our Chief Executive Officer and our Chief Financial Officer, the
effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended).
Based on this evaluation, our Chief Executive Officer and our Chief Financial
Officer have concluded that our disclosure controls and procedures are effective
to ensure that information we are required to disclose in reports that we
file
or submit under the Securities Exchange Act of 1934 (i) is recorded, processed,
summarized and reported within the time periods specified in Securities and
Exchange Commission rules and forms, and (ii) is accumulated and communicated
to
our management, including our Chief Executive Officer and our Chief Financial
Officer, as appropriate to allow timely decisions regarding required disclosure.
Our disclosure controls and procedures are designed to provide reasonable
assurance that such information is accumulated and communicated to our
management. Our disclosure controls and procedures include components of
our
internal control over financial reporting. Management’s assessment of the
effectiveness of our internal control over financial reporting is expressed
at
the level of reasonable assurance because a control system, no matter how
well
designed and operated, can provide only reasonable, but not absolute, assurance
that the control system’s objectives will be met.
Changes
in Internal Control over Financial Reporting
During
the three months ended December 31, 2006, there was no change in our internal
control over financial reporting identified in connection with the evaluation
required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that has materially
affected, or is reasonably likely to materially affect, our internal control
over financial reporting.
In
the
ordinary course of our business, we are involved in a limited number of legal
actions, both as plaintiff and defendant, and could incur uninsured liability
in
any one or more of them. Although the outcome of these actions is not presently
determinable, we believe that the ultimate resolution of these matters will
not
harm our business and will not have a material adverse effect on our financial
position, cash flows or results of operations. Litigation relating to the
semiconductor industry is not uncommon, and we are, and from time to time
have
been, subject to such litigation. No assurances can be given with respect
to the
extent or outcome of any such litigation in the future.
When
evaluating Microchip and its business, you should give careful consideration
to
the factors listed below, in addition to the information provided elsewhere
in
this Form 10-Q and in other documents that we file with the Securities and
Exchange Commission.
Our
quarterly operating results may fluctuate due to factors that could reduce
our
net sales and profitability.
Our
quarterly operating results are affected by a wide variety of factors that
could
reduce our net sales and profitability, many of which are beyond our control.
Some
of
the factors that may affect our quarterly operating results
include:
·
|
changes
in demand or market acceptance of our products and products of
our
customers
|
·
|
levels
of inventories at our customers
|
·
|
the
mix of inventory we hold and our ability to satisfy orders from
our
inventory
|
·
|
changes
in utilization of our manufacturing capacity and fluctuations in
manufacturing yields
|
·
|
our
ability to secure sufficient assembly and testing
capacity
|
·
|
availability
of raw materials and equipment
|
31
·
|
competitive
developments including pricing
pressures
|
·
|
the
level of orders that are received and can be shipped in a
quarter
|
·
|
the
level of sell-through of our products through
distribution
|
·
|
changes
or fluctuations in customer order patterns and
seasonality
|
·
|
ability
to timely introduce products
|
·
|
constrained
availability from other electronic suppliers impacting our customers’
ability to ship their products, which in turn may adversely impact
our
sales to those customers
|
·
|
costs
and outcomes of any current or future tax audits or any litigation
involving intellectual property, customers or other
issues
|
·
|
disruptions
in our business or our customers’ businesses due to terrorist activity,
armed conflict, war, worldwide oil prices and supply, public health
concerns or disruptions in the transportation
system
|
·
|
property
damage or other losses which are not covered by
insurance
|
·
|
general
economic, industry or political conditions in the United States
or
internationally
|
We
believe that period-to-period comparisons of our operating results are not
necessarily meaningful and that you should not rely upon any such comparisons
as
indications of future performance. In future periods our operating results
may
fall below our public guidance or the expectations of public market analysts
and
investors, which would likely have a negative effect on the price of our
common
stock.
Our
operating results will suffer if we ineffectively utilize our manufacturing
capacity or fail to maintain manufacturing yields.
The
manufacture and assembly of integrated circuits, particularly non-volatile,
erasable CMOS memory and logic devices such as those that we produce, are
complex processes. These processes are sensitive to a wide variety of factors,
including the level of contaminants in the manufacturing environment, impurities
in the materials used, the performance of our wafer fabrication personnel
and
equipment, and other quality issues. As is typical in the semiconductor
industry, we have from time to time experienced lower than anticipated
manufacturing yields. Our operating results will suffer if we are unable
to
maintain yields at approximately the current levels. This could include delays
in the recognition of revenue, loss of revenue or future orders, and
customer-imposed penalties for failure to meet contractual shipment
deadlines.
Our
operating results are also adversely affected when we operate at less than
optimal capacity. Lower capacity utilization results in certain costs being
charged directly to expense and lower gross margins.
We
are dependent on orders that are received and shipped in the same quarter
and
therefore limited in our visibility of future product
shipments.
Our
net
sales in any given quarter depend upon a combination of shipments from backlog
and orders received in that quarter for shipment in that quarter, which we
refer
to as turns orders. We measure turns orders at the beginning of a quarter
based
on the orders needed to meet the shipment targets that we set entering the
quarter. Historically, we have proven our ability to respond quickly to customer
orders as part of our competitive strategy, resulting in customers placing
orders with relatively short delivery schedules. Shorter lead times generally
mean that turns orders as a percentage of our business are relatively high
in
any particular quarter and reduces our backlog visibility on future product
shipments. Turns orders correlate to overall semiconductor industry conditions
and product lead times. Because turns orders are difficult to predict, varying
levels of turns orders make our net sales more difficult to forecast. If
we do
not achieve a sufficient level of turns orders in a particular quarter relative
to our revenue targets, our revenue and operating results may
suffer.
32
Intense
competition in the markets we serve may lead to pricing pressures, reduced
sales
of our products or reduced market share.
The
semiconductor industry is intensely competitive and has been characterized
by
price erosion and rapid technological change. We compete with major domestic
and
international semiconductor companies, many of which have greater market
recognition and substantially greater financial, technical, marketing,
distribution and other resources with which to pursue engineering,
manufacturing, marketing and distribution of their products. We may be unable
to
compete successfully in the future, which could harm our business.
Our
ability to compete successfully depends on a number of factors both within
and
outside our control, including, but not limited to:
·
|
the
quality, performance, reliability, features, ease of use, pricing
and
diversity of our products
|
·
|
our
success in designing and manufacturing new products including those
implementing new technologies
|
·
|
the
rate at which customers incorporate our products into their own
applications
|
·
|
product
introductions by our competitors
|
·
|
the
number, nature and success of our competitors in a given
market
|
·
|
our
ability to obtain adequate supplies of raw materials and other
supplies at
acceptable prices
|
·
|
our
ability to protect our products and processes by effective utilization
of
intellectual property rights
|
·
|
the
quality of our customer service and our ability to address the
needs of
our customers, and
|
·
|
general
market and economic conditions.
|
Historically,
average selling prices in the semiconductor industry decrease over the life
of
any particular product. The overall average selling prices of our
microcontroller and proprietary analog and interface products have remained
relatively constant, while average selling prices of our Serial EEPROM and
non-proprietary analog and interface products have declined over
time.
We
have
experienced, and expect to continue to experience, modest pricing declines
in
certain of our more mature proprietary product lines, due primarily to
competitive conditions. We have been able to moderate average selling price
declines in many of our proprietary product lines by continuing to introduce
new
products with more features and higher prices. We have experienced in the
past
and expect to continue to experience in the future varying degrees of
competitive pricing pressures in our Serial EEPROM products.
We
may be
unable to maintain average selling prices for our products as a result of
increased pricing pressure in the future, which could adversely impact our
operating results.
Our
business is dependent on selling through
distributors.
Sales
through distributors accounted for 65% of our net sales in fiscal 2006 and
during the first nine months of fiscal 2007. Our two largest distributors
together accounted for approximately 24% of our net sales in fiscal 2006,
and
21% of our net sales in the first nine months of fiscal 2007. We do not have
long-term agreements with our distributors and both we and our distributors
may
each terminate our relationship with little or no advanced notice. We believe
that customers recognize Microchip for its products and brand name and use
distributors as an effective supply channel.
During
fiscal 2006, we reduced the gross margin that certain of our distributors
earn
when they sell our products. We reduced these distributors’ gross margins
because we believe these distributors did not have sufficient technical sales
resources to properly address the marketplace for our products. We have added
a
significant number of technical sales employees throughout our worldwide
sales
organization to address the support requirements for both our OEM and
distribution customers. We cannot predict the impact, if any, that our actions
will have on our relationships with such distributors.
33
The
loss
of, or a disruption in the operations of, one or more of our distributors
could
reduce our net sales in a given period and could result in an increase in
inventory returns.
Our
success depends on our ability to introduce new products on a timely
basis.
Our
future operating results will depend on our ability to timely develop and
introduce new products that compete on the basis of price and performance
and
fulfill customer requirements. The success of our new product introductions
depends on various factors, including, but not limited to:
·
|
proper
new product selection
|
·
|
timely
completion and introduction of new product
designs
|
·
|
development
of support tools and collateral literature that make complex new
products
easy for engineers to understand and
use
|
·
|
our
ability to ramp new products to volume production,
and
|
·
|
market
acceptance of our customers’ end
products.
|
Because
our products are complex, we have experienced delays from time to time in
completing development of new products. In addition, our new products may
not
receive or maintain substantial market acceptance. We may be unable to timely
design, develop and introduce competitive products, which could adversely
impact
our future operating results.
Our
success also depends upon our ability to develop and implement new design
and
process technologies. Semiconductor design and process technologies are subject
to rapid technological change and require significant R&D expenditures. We
and other companies in the industry have, from time to time, experienced
difficulties in effecting transitions to advanced process technologies and,
consequently, have suffered reduced manufacturing yields or delays in product
deliveries. Our future operating results could be adversely affected if any
transition to future process technologies is substantially delayed or
inefficiently implemented.
We
must attract and retain qualified personnel to be successful, and competition
for qualified personnel is intense in our market.
Our
success depends upon the efforts and abilities of our senior management,
engineering and other personnel. The competition for qualified engineering
and
management personnel is intense. We may be unsuccessful in retaining our
existing key personnel or in attracting and retaining additional key personnel
that we require. The loss of the services of one or more of our key personnel
or
the inability to add key personnel could harm our business. Our employees’ and
officers’ employment is at will.
We
are dependent on several contractors to perform key manufacturing functions
for
us.
We
use
several contractors located in Asia for a portion of the assembly and testing
of
our products. We also rely on outside wafer foundries for a portion of our
wafer
fabrication. Although we own the majority of our manufacturing resources,
the
disruption or termination of any of our contractors could harm our business
and
operating results.
Our
use
of third parties involves some reduction in our level of control over the
portions of our business that we subcontract. Our future operating results
could
suffer if any contractor were to experience financial, operations or production
difficulties or situations when demand exceeds capacity, or if they were
unable
to maintain manufacturing yields, assembly and test yields and costs at
approximately their current levels, or if due to their locations in foreign
countries they were to experience political upheaval or infrastructure
disruption. Further, procurement from third parties is done by purchase order
and contracts. If these third parties are unable or unwilling to timely deliver
products or services conforming to our quality standards, we may not be able
to
qualify additional manufacturing sources for our products in a timely manner
or
at all, and such arrangements, if
34
any,
may
not be on favorable terms to us. In such event, we could experience an
interruption in production, an increase in manufacturing and production costs,
or a decline in product reliability, and our business and operating results
could be adversely affected.
We
may lose sales if our suppliers of raw materials and equipment fail to meet
our
needs.
Our
semiconductor manufacturing operations require raw materials and equipment
that
must meet exacting standards. We generally have more than one source for
these
supplies, but there are only a limited number of suppliers capable of delivering
various raw materials and equipment that meet our standards. The raw materials
and equipment necessary for our business could become more difficult to obtain
as worldwide use of semiconductors in product applications increases. We
have
experienced supply shortages from time to time in the past, and on occasion
our
suppliers have told us they need more time than expected to fill our orders
or
that they will no longer support certain equipment with updates or spare
and
replacements parts. An interruption of any raw materials or equipment sources,
or the lack of supplier support for a particular piece of equipment, could
harm
our business.
Our
operating results may be impacted by both seasonality and the wide fluctuations
of supply and demand in the semiconductor industry.
The
semiconductor industry is characterized by seasonality and wide fluctuations
of
supply and demand. Since a significant portion of our revenue is from consumer
markets and international sales, our business may be subject to seasonally
lower
revenues in the third and fourth quarters of our fiscal year. However, broad
strength in our overall business in recent periods has had a more significant
impact on our results than seasonality, and has made it difficult to assess
the
impact of seasonal factors on our business. The industry has also experienced
significant economic downturns, characterized by diminished product demand
and
production over-capacity. We have sought to reduce our exposure to this industry
cyclicality by selling proprietary products that cannot be easily or quickly
replaced, to a geographically diverse base of customers across a broad range
of
market segments. However, we have experienced substantial period-to-period
fluctuations in operating results and expect, in the future, to experience
period-to-period fluctuations in operating results due to general industry
or
economic conditions.
We
are exposed to various risks related to legal proceedings or claims.
We
are
currently, and in the future may be, involved in legal proceedings or claims
regarding patent infringement, intellectual property rights, contracts and
other
matters. As is typical in the semiconductor industry, we receive notifications
from customers from time to time who believe that we owe them indemnification
or
other obligations related to infringement claims made against the customers
by
third parties. These legal proceedings and claims, whether with or without
merit, could result in substantial cost to us and divert our resources. If
we
are not able to defend, resolve or settle a claim, obtain necessary licenses
on
commercially reasonable terms, reengineer our products or processes to avoid
infringement, we could incur uninsured liability in any of them, need to
take an
appropriate charge to operations, be enjoined from selling a material portion
of
our product line or using certain processes, suffer a reduction or elimination
in value of inventories, and as a result, our business, financial condition
or
results of operations could be harmed.
It
is
also possible that from time to time we may be subject to warranty or product
liability claims that could lead to significant expenses related to the defense
of such claims, increased costs associated with the replacement of affected
products, and a requirement to pay damages claims. Because the systems into
which our products are integrated have a higher cost of goods than the products
we sell, these expenses and damages may be significantly higher than the
sales
and profits we received from the products involved. While we specifically
exclude consequential damages in our standard terms and conditions, our ability
to avoid such liabilities may be limited by applicable law. We do have general
liability insurance, but it is unlikely that such insurance will cover all
claims or be of a sufficient amount to fully protect against such claims.
Costs
or payments we may make in connection with warranty or product liability
claims
may adversely affect our results of operations.
35
Further,
we sell to customers in industries such as automotive, aerospace, and medical,
where failure of their systems could cause damage to property or persons.
We may
be subject to product liability claims if our products cause the system
failures. Based on our historical experience, we believe that our risk of
exposure to product liability claims is currently low. However, we will face
increased exposure to product liability claims if there are substantial
increases in either the volume of our sales into these applications or the
frequency of system failures caused by our devices.
Our
failure to adequately protect our intellectual property could result in lost
revenue or market opportunities.
Our
ability to obtain patents, licenses and other intellectual property rights
covering our products and manufacturing processes is important for our success.
To that end, we have acquired certain patents and patent licenses and intend
to
continue to seek patents on our inventions and manufacturing processes. The
process of seeking patent protection can be long and expensive, and patents
may
not be issued from currently pending or future applications. In addition,
our
existing patents and any new patents that are issued may not be of sufficient
scope or strength to provide meaningful protection or any commercial advantage
to us. We may be subject to, or may ourselves initiate, interference proceedings
in the U.S. Patent and Trademark Office which can require significant financial
and management resources. In addition, the laws of certain foreign countries
do
not protect our intellectual property rights to the same extent as the laws
of
the United States. Infringement of our intellectual property rights by a
third
party could result in uncompensated lost market and revenue opportunities
for
us.
We
do not typically have long-term contracts with our
customers.
We
do not
typically enter into long-term contracts with our customers and we cannot
be
certain about future order levels from our customers. When we do enter into
customer contracts, the contract is generally cancelable at the convenience
of
the customer. Even though we have over 55,000 end customers and our ten largest
customers make up less than 15% of our total revenue, cancellation or
modification of long-term and short-term customer contracts could have an
adverse financial impact on our revenue and profits.
Further,
as the practice has become more commonplace in the industry, we have entered
into contracts with certain customers that differ from our standard terms
of
sale. Under these contracts we commit to supply quantities of products on
scheduled delivery dates. If we become unable to supply the customer as required
under the contract, the customer may incur additional production costs, lost
revenues due to subsequent delays in their own manufacturing schedule, or
quality related issues. Under these contracts, we may be liable for the costs
the customer has incurred. While we try to limit such liabilities, if they
should arise, there may be a material adverse impact on our results of operation
and financial condition.
Business
interruptions could harm our business.
Operations
at any of our manufacturing facilities, or at any of our wafer fabrication
or
test and assembly subcontractors, may be disrupted for reasons beyond our
control, including work stoppages, power loss, incidents of terrorism or
security risk, political instability, public health issues, telecommunications,
transportation or other infrastructure failure, fire, earthquake, floods,
or
other natural disasters. If operations at any of our facilities, or our
subcontractors’ facilities are interrupted, we may not be able to shift
production to other facilities on a timely basis. If this occurs, we would
likely experience delays in shipments of products to our customers and alternate
sources for production may be unavailable on acceptable terms. This could
result
in reduced revenues and profits and the cancellation of orders or loss of
customers. In addition, business interruption insurance will likely not be
enough to compensate us for any losses that may occur and any losses or damages
incurred by us as a result of business interruptions could significantly
harm
our business.
36
We
are highly dependent on foreign sales and operations, which exposes us to
foreign political and economic risks.
Sales
to
foreign customers account for a substantial portion of our net sales. During
fiscal 2006 and the first nine months of fiscal 2007, approximately 74% of
our
net sales were made to foreign customers. We purchase a substantial portion
of
our raw materials and equipment from foreign suppliers. In addition, we own
product assembly and testing facilities located near Bangkok, Thailand. We
also
use various foreign contractors for a portion of our assembly and testing
and
for a portion of our wafer fabrication requirements. Substantially all of
our
finished goods inventory is maintained in Thailand. Although we did not suffer
any material disruption in our business as a result of the recent military
coup
in Thailand, there can be no assurance that similar events in the future
in
Thailand or other countries will not adversely impact our
operations.
Our
reliance on foreign operations, foreign suppliers, maintenance of substantially
all of our finished goods in inventory at foreign locations and significant
foreign sales exposes us to foreign political and economic risks, including,
but
not limited to:
·
|
political,
social and economic instability
|
·
|
trade
restrictions and changes in tariffs
|
·
|
import
and export license requirements and
restrictions
|
·
|
difficulties
in staffing and managing international
operations
|
·
|
employment
regulations
|
·
|
disruptions
in international transport or
delivery
|
·
|
fluctuations
in currency exchange rates
|
·
|
difficulties
in collecting receivables
|
·
|
public
health conditions
|
·
|
economic
slowdown in the worldwide markets served by us,
and
|
·
|
potentially
adverse tax consequences.
|
If
any of
these risks materialize, our sales could decrease and our operating results
could suffer.
Interruptions
in information technology systems could adversely affect our
business.
We
rely
on the efficient and uninterrupted operation of complex information technology
systems and networks to operate our business. Any significant system or network
disruption, including but not limited to computer viruses, security breaches,
or
energy blackouts could have a material adverse impact on our operations,
sales
and operating results. We
have
implemented measures to manage our risks related to such disruptions, but
such
disruptions could negatively impact our operations and financial results.
In
addition, we may incur additional costs to remedy the damages caused by these
disruptions or security breaches.
The
occurrence of events for which we are self-insured, or which exceed our
insurance limits, may adversely affect our profitability and
liquidity.
We
have
insurance contracts with independent insurance companies related to many
different types of risk. However, we self-insure for some risks and obligations.
In these circumstances, we have determined that it is more cost effective
to
self-insure these risks than to pay the increased premium costs in place
since
the disruption in the insurance market after the events of September 11,
2001.
The risks and exposures that we self-insure include product defects, political
risks and patent infringement. Should there be a loss or adverse judgment
or
other decision in an area for which we are self-insured, then our financial
condition, result of operations and liquidity may be adversely
affected.
37
We
are subject to stringent environmental regulations, which may force us to
incur
significant expenses.
We
must
comply with many different federal, state, local and foreign governmental
regulations related to the use, storage, discharge and disposal of toxic,
volatile or otherwise hazardous chemicals used in our manufacturing process.
Although we believe that our activities conform to presently applicable
environmental regulations, our failure to comply with present or future
regulations could result in the imposition of fines, suspension of production
or
a cessation of operations. Any such environmental regulations could require
us
to acquire costly equipment or to incur other significant expenses to comply
with such regulations. Our failure to control the use of or adequately restrict
the discharge of hazardous substances could subject us to future liabilities.
Compliance
with future changes to securities laws and related regulations could result
in
increased costs to us.
Changes
in the laws and regulations affecting public companies, including the provisions
of the Sarbanes-Oxley Act of 2002 and rules enacted and proposed by the
Securities and Exchange Commission (SEC), The NASDAQ Stock Market®
(NASDAQ)
and the New York Stock Exchange (NYSE), resulted in significantly increased
costs to us in fiscal 2005 as we responded to their requirements. In particular,
complying with the internal control audit requirements of Sarbanes-Oxley
Section
404 in fiscal 2005 resulted in increased internal efforts and significantly
higher fees from our independent accounting firm. In fiscal 2006, our costs
associated with these activities were at approximately the same levels as
in
fiscal 2005. We expect our fiscal 2007 costs associated with these activities
to
be at approximately the same levels as in fiscal 2006. Further changes in
applicable legal or accounting requirements could result in additional costs
in
future periods.
Our
fiscal 2006 report on Form 10-K contained a report by our management on our
internal control over financial reporting including an assessment of the
effectiveness of our internal control over financial reporting as of March
31,
2006. Our fiscal 2006 Form 10-K also contained an attestation and report
by our
auditors with respect to our management’s assessment of the effectiveness of
internal control over financial reporting under Section 404. While these
assessments and reports did not reveal any material weaknesses in our internal
control over financial reporting, compliance with Section 404 is an ongoing
process and will be required for each future fiscal year. We expect that
the
ongoing compliance with Section 404 will continue to be both very costly
and
very challenging and there can be no assurance that material weaknesses with
not
be identified in future periods. Any adverse results from such ongoing
compliance efforts could result in a loss of investor confidence in our
financial reports and have an adverse effect on our stock price.
Recent
regulations related to equity compensation may adversely affect our ability
to
attract and retain key personnel and have adversely affected our earnings.
From
our
inception through fiscal 2006, we have used stock options and other long-term
equity incentives as a fundamental component of our employee compensation
packages and have accounted for them using the intrinsic value method of
APB No.
25, “Accounting for Stock Issued to Employees.” We believe that stock options
and other long-term equity incentives directly motivate our employees to
maximize long-term stockholder value and, through the use of vesting, encourage
employees to remain with Microchip. In December 2004, the Financial Accounting
Standards Board (“FASB”) issued Statement of Financial Accounting Standards
(“SFAS”) No. 123 (revised 2004), “Share-Based Payments,” (“SFAS 123R”) which
changed U.S. Generally Accepted Accounting Principles in such a way to require
us to record a charge to earnings for the fair value of employee stock option
grants and other share based compensation beginning in the first quarter
of
fiscal 2007. This regulation has negatively impacted our earnings for those
share based awards that vest in fiscal 2007 and later years. Furthermore,
adoption of SFAS 123R required us to make certain assumptions and judgments
in
the valuation of stock options that we may grant in the future. A change
in any
of those assumptions or judgments could change the compensation expense that
is
charged against our earnings and, consequently, adversely affect our results
of
operations. If there are any modifications or cancellations of the underlying
unvested securities, we may be required to accelerate, increase or cancel
any
remaining unearned share-based compensation expense. Future share-based
compensation expense and unearned share-based compensation will increase
to the
extent that
38
we
grant
additional equity awards to employees or assume unvested equity awards in
connection with acquisitions. See also Note 3 to the Condensed
Consolidated Financial Statements - Share-Based Compensation.
In
addition, recent NASDAQ regulations requiring shareholder approval for all
stock
option plans as well as recent NYSE regulations prohibiting NYSE member
organizations from giving a proxy to vote on equity-compensation plans unless
the beneficial owner of the shares has given voting instructions could make
it
more difficult for us to grant equity-based awards to employees in the future.
To the extent that these or other new regulations make it more difficult
or
expensive to grant equity incentives to employees, we may incur compensation
costs, productivity losses, change our equity compensation strategy or find
it
difficult to attract, retain and motivate employees, each of which could
materially and adversely affect our business.
The
future trading price of our common stock could be subject to wide fluctuations
in response to a variety of factors.
The
market price of our common stock has fluctuated significantly in the past
and is
likely to fluctuate in the future. The future trading price of our common
stock
could be subject to wide fluctuations in response to a variety of factors,
many
of which are beyond our control, including:
·
|
quarterly
variations in our operating results and the operating results of
other
technology companies
|
·
|
actual
or anticipated announcements of technical innovations or new products
by
us or our competitors
|
·
|
changes
in analysts’ estimates of our financial performance or buy/sell
recommendations
|
·
|
changes
in our financial guidance or our failure to meet such
guidance
|
·
|
general
conditions in the semiconductor industry,
and
|
·
|
worldwide
economic and financial conditions.
|
In
addition, the stock market has experienced significant price and volume
fluctuations that have particularly affected the market prices for many high
technology companies and that often have been unrelated to the operating
performance of such companies. These broad market fluctuations and other
factors
may harm the market price of our common stock.
The
outcome of currently ongoing and future audits of our income tax returns
by the
IRS could have an adverse effect on our results of
operations.
We
are
subject to continued examination of our income tax returns by the Internal
Revenue Service and other domestic and international tax authorities. We
are
currently under audit by the United States Internal Revenue Service (“IRS”) for
our fiscal years ended March 31,
1998,
1999, 2000 and 2001. As part of this ongoing audit, the IRS has proposed
certain
adjustments related to positions reflected on these returns. The IRS has
issued
formal assessments for these adjustments. We do not agree with these adjustments
and are appealing these assessments. The IRS is also currently auditing our
fiscal years ended March 31, 2002, 2003 and 2004. We regularly assess the
likelihood of adverse outcomes resulting from these examinations to determine
the adequacy of our provision for income taxes. There can be no assurance
that
the outcomes from these continuing examinations will not have an adverse
effect
on future operating results.
In
the event we make acquisitions, we may not be able to successfully integrate
such acquisitions or attain the anticipated benefits.
While
acquisitions do not represent a major part of our growth strategy, from time
to
time we may consider financially attractive and strategic acquisitions. Any
transactions that we complete may involve a number of risks, including the
diversion of our management’s attention from our existing business to integrate
the operations and personnel of the acquired business or possible adverse
effects on our operating results during the integration process. In addition,
we
may not be able to successfully or profitably integrate, operate, maintain
and
39
manage
any newly acquired operations or employees or maintain uniform standards,
controls, procedures and policies, and this may lead to operational
inefficiencies.
3.1
|
Amended
and Restated Bylaws amended through January 29, 2007 (incorporated
by
reference to an exhibit filed with our Form 8-K filed January
31,
2007)
|
4.1
|
First
Amendment to Rights Agreement dated January 29, 2007
|
10.1
|
Change
of Control Severance Agreement (incorporated by reference to
an exhibit
filed with our Form 8-K filed October 27, 2006)
|
10.2
|
Change
of Control Severance Agreement (incorporated by reference to
an exhibit
filed with our Form 8-K filed October 27, 2006)
|
10.3
|
2004
Equity Incentive Plan as amended and restated (incorporated by
reference
to an exhibit filed with our Form 8-K filed August 24,
2006)
|
10.4
|
Executive
Management Incentive Compensation Plan (incorporated by reference
to an
exhibit filed with our Form 8-K filed August 24, 2006)
|
10.5
|
Discretionary
Executive Management Incentive Compensation Plan (incorporated
by
reference to an exhibit filed with our Form 8-K filed August
24,
2006)
|
10.6
|
Management
Incentive Compensation Plan (incorporated by reference to an
exhibit filed
with our Form 8-K filed August 24, 2006)
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
32
|
Certification
of Chief Executive Officer and Chief Financial Officer Pursuant
to Section
906 of the Sarbanes-Oxley Act of
2002.
|
40
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
MICROCHIP
TECHNOLOGY INCORPORATED
|
|
Date:
February 6, 2007
|
By:
/s/
Gordon W. Parnell
|
Gordon
W. Parnell
|
|
Vice
President and Chief Financial Officer
|
|
(Duly
Authorized Officer, and
|
|
Principal
Financial and Accounting Officer)
|
41